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ABSTRACT

The need for a direct visual response system for the detection of organophosphorus
compounds stems from the continued threat and use of these toxic agents in military and
terrorist conflicts. The development of an enzyme-inhibitor triggered release system allows
for direct visual detection with high specificity. Mesoporous silica nanoparticles (MSNs)
have physical features that make them attractive as scaffolds for the construction of these
systems, such as pore diameters (20-500 Å) that can be synthetically controlled, large
surface areas (300-1500 m2g-1), large pore volumes, chemical inertness, stability at
elevated temperatures, and surfaces that can be easily functionalized. In our studies, the
dye Congo Red was loaded into the pores of MSNs, which were then capped by tethering
an enzyme (organophosphorus hydrolase (OPH) or acetylcholinesterase (AChE)) to the
external surfaces of MSNs through a competitive inhibitor (diethyl 4-aminobenzyl
phosphonate (DEABP) or tacrine, respectively). OPH has been extensively studied for its
ability to hydrolyze a wide range of organophosphorus compounds, rendering them nontoxic. AChE has been commonly used for organophosphate detection resulting from its
sensitivity to phosphorylation. Upon addition of organophosphorus compounds to
suspensions of the modified MSNs, the enzymes detached from the MSN surface, releasing
the dye and providing a visual confirmation of organophosphate presence. Enzyme kinetics
were studied using 31P NMR or UV-Visible spectroscopy; Congo Red release was also
monitored by UV-Visible spectroscopy. The system was sensitive and specific for
organophosphorus compounds both in phosphate-buffered saline and in human serum. The
rate of dye release directly correlated with the rate of organophosphorus conversion for
OPH and the rate of phosphorylation for AChE.
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CHAPTER 1: BACKGROUND ON TRIGGERED-RESPONSE SYSTEMS AND
MESOPOROUS SILICA NANOPARTICLES

1.1. Triggered-Response Systems
The unique ability of an organism or biological system to respond to an external
stimulus has driven research to understand these complex systems.1 Exploration of stimuli
responsive processes has in turn driven the development of new materials and systems to
mimic these complex response systems. The specific stimuli that results in a “triggeredresponse” of the system can be built into the material through synthetic or post-synthetic
functionalization.2-12 This requires the use of a material that can be readily tailored, to meet
the specific requirements (“trigger-specificity”) needed for the system to respond. This has
made the use of polymer-based materials particularly attractive, because they can be
produced in large amounts and chemical functionality can be incorporated during the
synthesis or post-synthetically with a variety of molecular architectures.1
The use of polymer-based materials as trigger-responsive systems has contributed
to the tremendous growth within this area over the past two decades. The breadth of
combinations of polymeric architectures and functionality has allowed for manipulation of
the material to effectively respond to a variety of small changes within their external
environment. One of the earliest examples of thermosensitive polymers, poly(Nisopropylacrylamide), which formed transitions from linear to globular across its lower
critical solution temperature (LCST = 32°C) in aqueous solution (Figure 1.1).1 Similarly,
the use of poly(acrylamide) crosslinking leads to the formation of polymeric gels that can
1

retain stability across the LCST during solvation/desolvation, resulting from changes in
temperature, or pH (Figure 1.1).1 Advancements in polymer-based materials have led to
materials that response to a variety of additional environmental and chemical changes such
as pH,13-17 temperature,18-22 magnetic fields,23-27 light28-29 or biological-based processes
such as enzyme signaling.30-34 The design of the material and response system controls
directly the ability of the system to react when exposed to one of these external stimuli.1,
25, 35-36

Figure 1.1: Coil-to-globular transition of poly(n-isoproplyacrylamide) dependent on temperature
(top) and gel solvation/desolvation of poly(acrylamide) dependent on temperature, or pH. 1

1.2. Design of a Triggered-Response System
Development of a triggered-response system based on a polymeric material
requires several key aspects to be adequately addressed. These include: the selection of the
2

base scaffold (polymeric material), the trigger (change in external environment) and the
response (chemical and/or physical). While each aspect can be individually considered as
the primary controlling design factor, the cooperation of all three components is required
in a complete triggered-response system.37 In triggered-release systems for detection
applications, an analyte molecule is the trigger releasing mechanism, activating a
secondary signal such as a colorimetric38-39 or fluorimetric39-40 response to indicate the presence
of the analyte such as the utilization of photo-induced electron transfer (PET) processes for
fluorescent chemosensors to indicate the presence of organophosphorus substrates. These
rely on an alcohol in close proximity to a tertiary amine with an appended fluorophore,
quenched by the PET. The introduction of an organophosphorus compound converts the
hydroxyl group to a phosphate ester followed by an ammonium salt, increasing the
fluorescence (Figure 1.2).41

Figure 1.2: Detection of organophosphorus compound using a PET sensor. 41

Increasing the “response” of the signal requires the immobilization of the
3

triggered-response system. Localization of the response increases the overall signal and
stabilizes system. The utilization of MSNs, specifically, allow for the localization of not
only the triggered-response system but offers stability, and rigidity to extend the life of the
system

through

control

of

the

physical

characteristics

and

post-synthetic

functionalization.42
1.3. Mesoporous Silica Nanoparticles (MSNs)
The use of a porous material offers several advantages over other polymeric
architectures in triggered-release systems, primarily a large internal pore volume that can
be used to load and retain large amounts of molecular cargo. Transporting the cargo within
the scaffold can offer protection from the external environment until the desired location
or stimulus is encountered. Controlling the loading and release of the cargo from the
interior volume through the porous structure can be directly manipulated by the selection
of pore diameter of the material. Silica-based materials are categorized based on their pore
size. Microporous, mesoporous, and macroporous materials have pore diameters of less
than 2 nm, 2-50 nm, and greater than 50 nm, respectively. Depending on the type of
molecules that need to be loaded, carried and delivered, selection of the proper pore
diameter and corresponding material can be determined.
Mesoporous silica nanoparticles (MSNs) offer several advantages over previous
mesoporous silica microspheres. They have a tunable particle size (50 – 300 nm) that has
shown to be endocytosed by living animals and plant cells without any significant
cytotoxicity. The spherical structure has shown to be rigid and stable to changes in heat,

4

pH and mechanical stress compared to other polymeric forms. In combination with these
attributes, MSNs have pore diameters corresponding to the sizes of many biomolecules.37
This was seen with the MSN-based system that facilitated the intercellular delivery of
cyclic adenosine monophosphate (cAMP), loaded in the interior pore volume.
Manipulation of the MSN surface resulted in the immobilization of a gluconic acidderivatized insulin that capped the material and was released in the presence of excess
blood glucose (Figure 1.3).43 This has propelled the use of MSNs in a variety of
applications such as drug delivery,42,

44-45

bioimaging,46-47 biosensing,43,

48

and

biocatalysis.49-51

Figure 1.3: Insulin-capped MSN. The removal of cap (a) is triggered by blood glucose (b) to release
cAMP (c).43

1.3.1. Synthesis of MSNs
The development of MSNs has progressed over the last two decades from their
5

application in several areas such as adsorption, chromatography, sensors, and drug
delivery.45, 52 This stemmed from their original development as a new class of molecular
sieves by the Mobil oil company. Typical microporous molecular sieves (zeolites), used
for separations, were limited by their small pore diameters and the molecular range in
which they would be useful for separations. The development of MCM-41 in 1992, the
first mesoporous material, began a surge of new materials that retained the large surface
areas of zeolites but had pore diameters greater than 2 nm. The most prominent
representatives of this emerging material were the class of MCM-type materials. The use
of ionic structure directing surfactants during the condensation of a silica precursor under
basic conditions allowed for the development of several different pore structures (Figure
1.4). This included the 2-dimensional, hexagonally arranged pores of MCM-41, MCM-48
with a 3-dimensional, cubic arrangement and MCM-50 that had a laminar structure.52-54
Alternatively, other synthetic methods were employed using variations in structure
directing agents, and under acidic conditions those led to the development of SBA-type
materials, such as SBA-15, using triblock copolymer templates. 45

6

Figure 1.4: Scheme of the formation mechanism of MCM-41.TEOS: tetraethoxysilane.45

Since this initial development, a broad range of synthetic procedures have been
developed. Manipulation of reaction conditions (pH), the silica monomers, and structuredirecting surfactants chosen can all be used to control the synthesis of the desired material.
These factors influence the type of interaction (electrostatic or hydrogen bonding) between
the surfactant (S) and silica (I) (Figure 1.5). Electrostatic interactions can be manipulated
by the pH of the reaction mixture and the type of surfactant. Under basic conditions, a
cationic surfactant has a direct interaction with the silica giving a S+ - S- interaction.
Alternatively, acidic conditions below the isoelectric point of the Si-OH (less than pH = 2)
require the use of a counter-ion (X-) to mediate the S+ - I+ interaction. The use of an anionic
surfactant has similar interactions depending on the pH of the reaction conditions. Under
acidic conditions the interaction is S- - I+, while basic conditions require the addition of a
7

mediator (M+) for the S- - I- electrostatic interaction. When uncharged silica is used, a nonionic surfactant (I0) can form hydrogen bonds to have a S0 – I0 interaction. Hydrogen
bonding can also occur in acidic conditions with the interaction of a charged silica surface
and ion to form an ion pair (IX)0 to have a S0 – (IX)0 interaction. With numerous
combinations of surfactant, silica and pH, further manipulation of the concentrations,
temperature and reaction time allows additional control over particle diameter, morphology
and pore structure of the MSN.52, 55-56

Figure 1.5: Interactions between the inorganic species and the head group of the surfactant with
consideration of the possible synthetic pathway in acidic, basic or neutral medial. a) S+I-, b) S+X-I+, c)
S-M+I-, d) S-I+, e) S0I0/N0I0 and f) S0(XI)0.52

8

1.3.2. Physical Characteristics of MSNs
The primary physical characteristics that govern the ability of the scaffold to be
an effective release system are pore diameter, pore structure, surface area, pore volume
particle diameter, and particle morphology. Depending on the molecular cargo to be
transported and delivered, adjustments to these characteristics can greatly affect loading
and/or release. Previous research into the influence of each of these characteristics has
given insight on how each one specifically controls the overall function of the system.45
In general, pore diameter can drastically change the ability of a material to not
only load a desired cargo but affect the release rate. Dependent on the size of the cargo,
changing the diameter of the pore can increase or decrease the total amount loaded.
Examples of this include the loading SBA-15 with a large cargo, such as a bovine serum
albumin (BSA), in which increasing the pore diameter from 8.2 to 11.4 nm can almost
double the loading from 0.15 grams BSA per gram of SBA-15 to 0.27 g/g. amount. This
can be attributed to the steric constraints of pore diameter, and ability for the BSA to adjust
its confirmation to pack tightly once in the interior.57 In another example, release studies
using ibuprofen have shown pore diameter to drastically control delivery. Increasing the
pore diameter by only 11 Å can increase the release rate fivefold.58 When factoring in the
desired cargo that will be transported and its relative size, the selection of the proper pore
diameter can be made.
Similarly, the availability of several different pore structures based on pore
connectivity and geometry have shown to contribute to the loading and release of cargo. A
SBA-1 mesoporous material with 3D cubic interconnected resulted in faster release of
9

ibuprofen compared to SBA-3 mesoporous material with a hexagonal geometry with a
similar surface area, and pore diameter but unconnected pores. This was attributed to the
interconnections between pores offering easier diffusion throughout the material, resulting
in faster mass transport and release.45, 59-61
A major benefit of using mesoporous materials are their high surface areas and
large pore volumes. While a small amount of surface area is derived from the exterior
surface of the particle, the vast majority (at least 95% depending on the particle diameter)
is from the interior surface of the material. This influences the quantity of cargo that can
be loaded, controlled by the interaction of the cargo with the interior pore wall. Cargo that
interacts with the interior pore surface has a direct correlation of surface area to the loading
capacity of the material. Comparisons of unmodified materials with different surface areas,
MCM-41 (1157 m2 g-1) versus SBA-15 (719 m2 g-1), have shown almost a twofold increase
in loaded alendronate due to the direct interaction with the surface hydroxyl groups with
hydrophilic molecules.60, 62 For hydrophobic molecular cargo, interior modification of the
surface hydroxyl groups such as with 3-aminoproplytriethoxysilane, has shown to increase
the loading of camptothecin.63 Whether the interaction with the pore wall occurs or not,
filling of the remaining interior can be greatly influenced by the pore volume. Materials
that have larger pore volumes, SBA-15 (1.1 cm3 g-1) versus mesocellular silica foams (1.9
cm3 g-1) have shown to load almost double the amount of cargo. This can be attributed to
the packing of the cargo within the pore, limited by only the dimensions of the cargo.45, 57,
64
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1.3.3. Functionalization of MSNs
The most beneficial aspect of using MSNs is their ability to easily modified with
specific organic functional groups. Incorporation of a broad range of possible
functionalities allows for the tailoring of the material as a specific triggered-release system.
The three main ways of incorporating these new functionalities are through post-synthetic
functionalization (grafting), co-condensation, and by using bridged alkoxysilane
precursors ((RˈO)3Si-R-Si(ORˈ)3) (Figure 1.6). Each of these techniques differs in their
approach to which the organic functionality can be added. Periodic mesoporous
organosilicas (PMOs), created from bridged silanes, were designed to incorporate the
functionality directly into the 3D network of the silica structure. This can be accomplished
through the use of a bridge organosilica precursor, allowing for functionalization within
the pore walls of the material.52,

65-66

Co-condensation relies on the addition of

trialkoxyorganosilanes ((RˈO)3SiR) in a one-pot synthesis, containing the surfactant and
silica precursor. This results in organic modification positioned on the walls of the
material.52
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Figure 1.6: Silica-based mesoporous organic-inorganic hybrid materials.52

While each of these approaches result in the direct addition of organic moieties,
both have several disadvantages for the use as a triggered release system. In general, PMOs
often result in a disordered pore structure with a wide range of pore diameters, limiting the
control of pore size. Similar effects have been seen with the co-condensation method, in
which reductions in pore diameter, pore volume, and surface area can vary depending on
the concentration of the trialkoxyorganosilane added. Uneven distribution, difficult access
to the organic functionality, and the lack of compatible organic moieties to incorporate
using these methods have all limited their use.52
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1.3.3.1. Post-Synthetic Functionalization: Grafting
Grafting has become the primary method for adding organic functionality to
MSNs when developing a triggered-release system. The complexity of building a system
that can retain cargo and release it in the presence of a certain trigger requires specific
functionality to be post-synthetically added to the scaffold. After synthesizing the desired
scaffold, the exterior and/or interior can be functionalized with the condensation of
organosilanes of the type (RˈO)3SiR onto the MSN surface, allowing for a broad range of
functionalities to be added, depending on the application.52
There are a variety of ways to post-synthetically control the location of the
organosilane. If modification with the same organosilane is desired on both of the exterior
and interior, removal of the interior surfactant template through calcination is performed.
This allows the organosilane to modify the exterior surface and the now opened interior
pore surface of the material. To modify the exterior surface and interior surface
differentially, the surfactant can be retained, blocking the pores of the material and limiting
the amount of organosilane entering the material. After grafting, the removal of surfactant
can be accomplished through an extraction process, exchanging the surfactant with an
appropriate solvent. With the opening of the pores of the material, a second grafting process
can proceed adding a separate organic functionality to the interior pore surface.42, 67
Interior (pore) modification has several advantages for controlling the loading and
release of cargo. Depending on the physical and electrostatic characteristics of the cargo,
the degree of interaction can be easily manipulated. Some systems require a strong
interaction (covalent bonding, electrostatic interaction versus weak interactions (hydrogen
13

bonding and/or physical adsorption) of the interior and cargo to control aspects of the
delivery kinetics and rate of diffusion from the interior pore volume.42, 68-70 Manipulating
the interior separate from the exterior allows for tailoring of the material for the cargo that
will be loaded and released from the system. The only limitations of interior modification
are controlled by the ability of the silane to enter the interior pore system and the degree of
modification. Depending on the size of the silane, pore diameter can limit the organosilane
that can be introduced into the interior of the material. Additionally, organosilane
modification has to be controlled to limit the propensity for pores to become blocked by
extensive modification.52
Exterior modification of MSNs has been at the forefront of research on the
tailoring of the material to interact with its external environment. Depending on the type
of external trigger that is required to release the cargo, exterior modification plays an
important role in helping to retain the loaded cargo. This has expanded the development of
a “gating” systems in which access to the pores is restricted by blocking or modifying the
pore to entrap the loaded cargo.
1.3.4. MSN Gating for Triggered Delivery of Cargo
Gating is a specific modification approach that restricts access to the pore of the
MSN, acting as a “gate”. Gating can be separated into three main categories based on the
method of retaining the cargo. The first is based on the direct attachment of the cargo to
the interior surface of the material through coordinate or covalent attachment. This allows
retention and transport of the cargo until the presence of the trigger, which can be a
reducing agent,71-73 light,74-78 a pH change,75-76 or a temperature change,79-81 such as with
14

the functionalization of a MSN with an azobenzene derivative that will undergo a cis-trans
photoisomerization induced by light at 413 nm. The switch from cis to trans causes a
propeller type motion, pushing the loaded molecular cargo out of the pores of the MSN
(Figure 1.7).77

Figure 1.7: Release of cargo by cis-trans photoisomerization. 77

Another approach to a gating system has been to fully coat the exterior surface to
block the pores. Coating can be accomplished with a variety of materials such as
polymers,19, 82-85 polyelectrolyte mulitilayers86-87 or biomolecules.88-90 The release of the
coatings from the surface of the MSNs allows for the loaded cargo to escape. The trigger
can be based on changes in pH,82, 85-87 temperature,19, 82, 84-85 chemical environment88 or on
molecular recognition using enzymes83 or competitive molecules.89-90 This has been seen
15

by exterior surface functionalization with the long chain polymer, poly(Nisopropylacrylamide). At a temperature of 25°C, the chain is extended to allow for the
loading of cargo. Increasing the temperature to 35°C, the chain is in a coiled confirmation,
blocking the pores and retaining the loaded cargo until a decrease in temperature (Figure
1.8).84

Figure 1.8: Coating approach to gating of MSN using a temperature sensitive poly(Nisopropylacrylamide).84

The third gating method involves the direct blocking of the pore with a bulky
organic molecule (i.e. cyclodextrin14, 28, 33, 91-95), nanoparticle (i.e. Au,29, 96 CdS,97 Fe3O427,
98-99

or ZnO100) or long chain molecules (polyamine101-102). The introduction of an external

stimulus such as light,28-29, 96 pH,14, 91-92, 94-96, 99-102 enzyme,33, 93 magnetic field98 or reducing
agents27, 97 results in the loss of the pore blockage and subsequent release of the cargo. This
has been seen with blocking the pores with carboxylic acid-modified cadmium sulfide
nanoparticles (CdS). Modification of the interior pore of the MSN with a long-chain amine,
16

containing a disulfide bond, allows for a peptide coupling between the CdS and MSN. This
allows for entrapment of the loaded drug until the introduction of dithiothreitol (DTT) to
cleave the disulfide bond, releasing the CdS, and opening the pores (Figure 1.9).97

Figure 1.9: Direct blocking with a CdS nanoparticle with a reducing agent sensitive disulfide bond. 97

Gating systems have an advantage over previous triggered-release systems that
rely on simply changes in temperature, pH, or chemical environment. Gating allows for
molecular recognition systems to control the release of molecular cargo from the MSN.
This has been seen with the example of glucose oxidase tethered to an MSN surface
through an enzyme-inhibitor interaction to retain the loaded Rhodamine B cargo. In the
presence of the desired enzyme substrate (glucose), glucose oxidase is released from the
surface to break down glucose, opening the pores of the material (Figure 1.10).103
Narrowing down the release-trigger to a specific molecular recognition interaction reduces
17

the potential for premature release of the molecular cargo. This has led the use of these
systems in areas in which specificity is essential, such as detection.104-105

Figure 1.10: Molecular recognition controlled by recognition of substrate (glucose) by the degrading
enzyme (glucose oxidase).103

1.4. Detection Through Gating Systems
An emerging category of the application of gating systems to the problems of
molecular detection and sensing, specifically on the design of small-molecule based
systems.106-108 Free standing small molecule-based sensors have been widely used but
several drawbacks have pushed for the integration of these systems within solid supports.
A solid support allows for greater stability of the sensor and additional functionalization
can be added to create a more effective detection system.25 Integration into solid supports
has been applied to the detection of a variety of analytes such as ions,109 biomolecules,107
explosives108 and pesticides.110
18

1.4.1. Molecular Recognition
The goal of developing more complex detection systems is generally to enhance
the sensitivity of the system. The use of molecular recognition systems, where the response
is based on a specific molecular interaction, can lead to sensitive detection systems.104-105
These are often based on biomolecules such as enzymes, amino acids, or nucleic acids. For
example, the affinity of an enzyme for its substrate, can be built into a detection system,
drastically increasing its sensitivity. In particular, this has been the trend in the
development of biosensors for the detection of organophosphate pesticides.
1.4.2. Organophosphate Detection
Organophosphate detection and decontamination has continued to be an evolving
field of research. Ranging from less toxic pesticides to extremely toxic nerve agents,
organophosphorus compounds can have detrimental effects, in which the structural
features will be discussed in Chapter 4. The neurotoxicity of these compounds arises from
their inhibitory effect on acetylcholinesterase (AChE). AChE is responsible for the
hydrolysis of acetylcholine (ACh), a neurotransmitter used in neuronal communication
(Figure 1.11).111-112 Exposure to an organophosphate results in the phosphorylation of a
serine residue within the catalytic site of AChE. This inhibits the ability of AChE to
hydrolyze ACh into choline and acetate, causing a buildup of ACh in nerve synapses and
resulting in paralysis and death.38-40, 110, 113-115
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Figure 1.11: Acetylcholinesterase (AChE) and its active site in the presence of acetylcholine (ACh).111112

Past methods for the detection of organophosphates have consisted of
instrumental techniques such as gas chromatography, mass spectrometry, and NMR
spectroscopy. While these techniques offer low detection limits, problems with portability,
real-time and complex use, and false positives remain.

115-125

To address some of these

issues, research has shifted towards the development of colorimetric38-39 and fluorimetric3940

response systems, deriving from previous extensive use in small molecule detection. 106,

126-128

Optical response systems offer a rapid, highly portable, and quantitative detection

method, often using only the naked eye. This helps to address issues of real-time and ease
of use of these systems by military personnel and civilians. 38-39, 129
1.4.2.1. Optical Biosensors
The development and use of optical biosensors for organophosphate detection
covers a broad range of detection strategies. These strategies can be categorized by the
triggering response method, whether inhibition or catalysis. (Each mechanism activates a
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secondary action, giving the optical response). In triggered systems, using catalysis, the
use of a bacterial enzyme capable of hydrolyzing organophosphotriesters allows specificity
to be controlled by a substrate-enzyme interaction. Two of these bacterial enzymes are
organophosphorus acid anhydrolase (OPAA) and organophosphorus hydrolase (OPH).
OPAA has a high specificity for hydrolysis of P-F and P-CN bonds, which are present in
the nerve agents sarin and tabun but cannot hydrolyze P-O or P-S bonds that are present in
pesticides such as parathion, malathion, and demeton-s.
OPH has the ability to hydrolyze a wide variety of organophosphorus compounds
through the cleavage of the P-O, P-F, P-S or P-CN group, with the catalytic rate dependent
on the bond.130-131 After the hydrolysis reaction, the production of an acid (XH) and alcohol
offer a variety of ways in which to optically activate the biosensor. The acid can trigger a
response from pH-sensitive dye, whereas the alcohol is often chromophoric, and can be
tracked through spectroscopic techniques such as UV-Visible spectroscopy (Figure
1.12).132
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Figure 1.12: Reaction scheme for the OPH-catalyzed hydrolysis of organophosphates.132

Inhibition-based

biosensors for organophosphates require the

use of

cholinesterases such as AChE. The activity of AChE hydrolyzing ACh is measured and
compare to the activity of AChE after exposure to an organophosphate. The
organophosphate will phosphorylate the active site of AChE, preventing hydrolysis of
ACh, and slowing the hydrolysis rate. This allows the tracking of AChE activity and its
inhibition by secondary process to give an optical signal.129 The sensitivity of AChE to
organophosphates has been routinely explored, most notably by the widely used
colorimetric method for tracking the activity of AChE, the Ellman’s method. The Ellman’s
method tracks the hydrolysis of acetylthiocholine (AtCh) to its product, thiocholine (tCh)
that reacts with the Ellman’s reagent, 5,5-dithio-bis-(2-nitrobenzoic acid), to give a color
product (2-nitro-5-thiobenzoate) that can be tracked by UV-Visible spectroscopy.133-134
While each approach for the primary mechanism of the biosensors has shown
22

several benefits, they are still based on secondary signals. This limits the benefits of having
an optical system that can effectively notify an individual of the presence of a toxic
substance, where time is crucial. This flaw has pushed organophosphate detection in new
directions that continue the use of an optical detection method but rely on a direct response
to an organophosphate.
1.5. Rationale for This Study
The rationale for this study is that the use of a molecular recognition system for
organophosphate detection will eliminate the problem of false positives seen with previous
detection systems. To do this, the use of a MSN as the scaffold to contain the optical signal,
the dye Congo Red, is capped with an enzyme to block the pores to retain the loaded dye.
The mode of attachment of the enzyme (OPH or AChE) was through the use of a
competitive inhibitor of the enzyme. Testing of the triggered-release mechanism with
either substrate or organophosphates was thoroughly explored to test the stability of the
tethering, and relate the dye release kinetics to the rate of AChE inhibition.
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CHAPTER 2: SIMULTANEOUS DETECTION AND DECONTAMINATION OF
ORGANOPHOSPHORUS COMPOUNDS USING A TRIGGERED ENZYME
RELEASE SYSTEM

2.1. Introduction
Organophosphorus compounds have an expansive toxicity range from pesticides
to chemical warfare agents (CWAs), specifically nerve agents. Neurotoxicity arises from
the inhibitory effect on acetylcholine esterase that causes buildup of acetylcholine in nerve
synapses resulting in paralysis and death.1-7 The extreme toxicity and extent of destruction
nerve agents can and do have caused resulted in part the development of the Chemical
Weapons Convention. This was an agreement to stop the production and eliminate
stockpiles of all CWAs but the continued exploitation during conflicts has persisted.8-9 The
recurrent threat of exposure to military organizations and the general public within conflict
zones has continued the effort towards the design of more effective detection and
degradation systems.
Detection of nerve agents has been at the forefront of detection and degradation
systems. The ease of exposure and the severity of toxicity have driven this area to include
a wide range of detection methods. The major drawback of these systems has been
problems with portability, real-time and complex use, and false positives.7, 10-19 To address
some of these issues, a shift towards the use of colorimetric3-4 and fluorimetric4-5 response
systems has been seen. Optical response systems offered a rapid detection method, often
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using only the naked eye as the detector. Though these systems have complications with
false positives even now. 3-4
While detection of toxic organophosphorus compounds has seen progress,
degradation of these species is equally as important. There are several different methods
that have been developed to destroy or degrade CWAs including incineration, hydrolysis
or oxidation.19-20 Often though, these degradation methods result in problems such as the
transportation of the CWA’s to only a few incineration plants and the use of toxic or
corrosive chemicals such as bleach that further hinder decontamination.2, 19, 21 A way to
circumvent these problems is through the use of enzymes to degrade certain CWAs.2
Enzymatic degradation of organophosphorus pesticides and nerve agents (Figure 2.1)20
has been performed with organophosphorus hydrolase enzymes (OPH).2, 6, 22-26 The general
scheme for deactivating organophosphorus compounds is through the hydrolysis of P-S,
P-O, P-F, and P-CN bonds.22, 27

Figure 2.1: a) Structures of organophosphorus pesticides and nerve agents. b) General enzymatic
hydrolysis.
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While there has been great advancement in the areas of detection and
decontamination separately, ideally, an all in one detection and decontamination system is
desired. When considering the use of these systems in real-world applications, it is much
more efficient to have a dual system. There are several aspects to consider when designing a
dual system such as who is using this system, how effective is it and how much does this
system cost. The goal of the current system addresses these issues by having a visual
detection system that is easily discernable by an individual without specialized training,
costs kept low by using a scaffold that can be produced in large quantities and utilizing a
dual detection and decontamination system for increased efficiency.
The use of OPH as an efficient decontamination method has shown promise.
Using an enzyme to accomplish the degradation of organophosphorus compounds has
many advantages over the other common methods of degradation. The use of OPH allows
for fast and efficient catalytic hydrolysis without leaving further toxic byproducts. This
makes the system environmentally friendly and allows the system to be easily transported
to areas that have been contaminated. The only complications with using an enzyme are
their tendency to denature, however this can be avoided through immobilization.28
For the detection method for this system, visual indication will be used to keep
the system easy to use. By only having to use the naked eye as a detector, portability is
possible without the use of a physical detection system. There are a wide range of dyes
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that can be used to give a quick response that the decontamination process is occurring.
To combine the detection and decontamination aspects, porous silica can be used
as a scaffold to integrate these two systems. Using a porous silica support, specifically
mesoporous silica, has several advantages. Immobilization will help prevent denaturation
of OPH to extend the lifetime and has even been shown to increase the activity of OPH.23,
28

The large range of pore diameters (2-50 nm), large surface areas (300-1500 m2g-1) and

surfaces that can be easily functionalized, allows the mesoporous silica to be tailored.28-30
Utilization of the mesoporous silica scaffold will begin by first loading dye into
the interior pore volume of the mesoporous silica to which OPH can be immobilized onto
the silica surface. This serves a dual functionality of blocking the pores to keep the dye in,
as well as decontaminating organophosphorus compounds upon its triggered release. To
temporarily hold OPH to the surface, a competitive inhibitor of OPH can be used and will
release OPH when in the presence of an organophosphorus compound (Figure 2.2). This
system would offer an effective detection and decontamination method that is easily
synthesized and simple to use by showing a visual change caused by a triggered release of
the decontaminate.
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Figure 2.2: A model of simultaneous detection and decontamination of organophosphorus
compounds.

2.2. Experimental Section
2.2.1. Materials and Instrumentation
All materials were purchased from Sigma-Aldrich, VWR and Life Technologies,
unless otherwise noted. Nuclear Magnetic Resonance (NMR) spectra were recorded on a
Bruker AVANCE III 500 MHz high-field NMR spectrophotometer with a multi nuclear
observation capability. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at
100°C for 15 minutes to get rid of water. N2 adsorption and desorption isotherms were
obtained on a Micromeritics TriStar instrument. Surface areas were measured using the
Brunauer-Emmett-Teller (BET) method and pore size distributions were calculated from a
modified Kruk, Jaronic and Sayari (KJS) method using the adsorption branch.
2.2.2. Synthesis, Functionalization and Characterization of APMS
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2.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)
APMS was synthesized as previously described. 31-32
2.2.2.2. Synthesis of APMS-(s)-NH2
Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol
(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each cycle. The
degree of modification was characterized by thermogravimetric analysis (2.02 mmol
modification/g APMS) and the physical properties characterized by nitrogen physisorption.
The resulting APMS was then placed under vacuum to keep dry until further modification.
2.2.2.3. Synthesis of APMS-(s)-NH-COOH
Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg)
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were
followed by drying overnight. The degree of modification was characterized by
thermogravimetric analysis (0.606 mmol modification/g APMS) and the physical
properties characterized by nitrogen physisorption. The resulting APMS-(s)-NH-COOH
was then placed under vacuum to keep dry until further modification.
2.2.2.4. Synthesis of APMS-(s)-DEABP
To 200 mg APMS-(s)-NH-COOH suspended in 40 mL MES buffer (50 mM, pH
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= 6.0), N-hydroxysuccinimide (10, 28 or 50 mg) was added and stirred at room temperature
for 20 minutes. To this solution N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide
hydrochloride (22, 55 or 90 mg) was added and stirred an additional 2.25 hours. A solution
of diethyl 4-aminobenzyl phosphonate (DEABP) (20, 53 or 78 mg) in acetonitrile (dry, 1
mL) was then added slowly and stirred for 21 hours. The particles were collected by
vacuum filtration and washed with deionized H2O and acetonitrile and left to dry overnight.
The degree of modification (0.151, 0.214, 0.414 mmol modification/g APMS, respectively)
was determined by thermogravimetric analysis and the physical properties characterized
by nitrogen physisorption. The resulting APMS-(s)-DEABP was then placed under
vacuum to keep dry until further modification.
2.2.2.5. Synthesis of APMS-(s)-DEABP-OPH
To 5 mg APMS-(s)-DEABP suspended in 425 µL CHES buffer (20 mM, pH =
9.0), 175 µL OPH (453 µg/mL) was added and placed on a rotating platform for
21.75 hours. The sample was centrifuged, supernatant removed and immobilized OPH
determined. The particles were washed with CHES buffer (3X) and re-suspended in the
appropriate amount of CHES buffer for kinetics testing. Free OPH concentrations and
amounts of OPH immobilized onto APMS-(s)-DEABP were calculated using the Bradford
method (reference in main text) from a standard bovine serum albumin (BSA) calibration
curve. Triplicate samples measured for standard curve.
2.2.3. Measurement of Enzymatic Activity.
2.2.3.1. 31P NMR Assay
Samples were spun at 20 rps at 25 °C and 31P shift was referenced to external
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H3PO4 shift standard at 0 ppm. A 90° phosphorous pulse prior to acquisition was used to
give maximum signal response for shorter acquisition time. An aliquot of deuterium oxide
(50 µL) was added to each sample after the reaction was terminated but before transfer to
the NMR tube for a field lock. A 100 ppm sweep width was used with approximately 20200 scans depending on the conversion rate of the reaction.
2.2.3.2. Degradation of Paraoxon by Free OPH
To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and OPH
(2.5 µg/mL, 20 µL) were added. A paraoxon stock (301 mM in methanol) was prepared
and an aliquot added to give varying concentrations of paraoxon (2.45- 6.14 mM) in the
solution and the time recorded. The sample was shaken for two minutes at which time OPH
was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each sample was run in
triplicate and the enzymatic activity determined using 31P NMR with a phosphoric external
standard.
2.2.3.3. Inhibition of Free OPH by DEABP
To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and OPH
(0.05 µg) were added. A stock solution of DEABP (100.5 mM) was prepared to which an
aliquot was added to give varying concentrations of DEABP (16.4, 24.6 and 30.8 mM) in
the reaction. The sample was shaken for five minute and then from a paraoxon stock (301
mM in methanol), an aliquot was added to give varying concentrations of paraoxon (2.456.14 mM) in the reaction and the time recorded. The sample was shaken for two minutes
at which time OPH was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each
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sample was ran in triplicate and the enzymatic activity determined using 31P NMR with a
phosphoric external standard.
2.2.3.4. Degradation of Paraoxon Using APMS-(s)-DEABP-OPH
To CHES buffer (20 mM, pH= 9.0, 440 µL), CoCl2 (1.25 mM, 20 µL) and APMS(s)-DEABP-OPH (0.05 µg OPH total) were added. From a paraoxon stock (301 mM in
methanol), an aliquot was added to give varying concentrations of paraoxon (2.45- 6.14
mM) in the reaction and the time recorded. The sample was shaken for 2 minutes at which
the entire reaction mixture was filtered using a 0.2µm nylon membrane (25 mm) syringe
filter. Each sample was run in triplicate and the enzymatic activity determined using
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NMR with a phosphoric external standard.
2.2.4. Congo Red Loading and Release Using OPH-Tethered Particles
2.2.4.1. Loading of Congo Red (APMS-CR-(s)-DEABP)
Congo Red (CR) (51.9 mg) was added to a citrate buffer (10 mL, 0.1 M, pH 2.3)
to make a CR stock. In a typical loading procedure, APMS-(s)-DEABP (11.5 mg) was
shaken (20 hr) with the CR stock (5 mL, 7.45 mM). The sample was centrifuged and the
supernatant measured by UV-vis to determine the amount of CR loaded. The material
was washed once with CHES buffer (20 mM, pH= 9.0) to prepare for loading with OPH.
2.2.4.2. Loading OPH (APMS-CR-(s)-DEABP-OPH)
To 11.5 mg APMS-CR-(s)-DEABP suspended in 400 µL CHES buffer (20 mM,
pH = 9.0), 200 µL OPH (818 µg/mL) was added and placed on a rotating platform for
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21.75 hours. The sample was centrifuged, supernatant removed and immobilized OPH
determined. The particles were washed with CHES buffer until all non-encapsulated CR
was removed. The particles were then re-suspended in the appropriate amount of CHES
buffer for kinetics testing.
2.2.4.3. Release of Congo Red from APMS-CR-(s)-DEABP-OPH
In a typical reaction, to CHES buffer (20 mM, pH= 9.0, 1185 µL), CoCl 2 (1.25
mM, 60 µL) and APMS-(s)-OPH-DEABP (25.5 µg OPH total) were added. Testing using
cell culture media was a 10% Fetal bovine serum (FBS) in Dulbecco’s Modified Eagle
Medium (DMEM) (no phenol red, glutamine or glucose, pH 7.4). A typical reaction
sample, unless noted otherwise, was shaken for 15 minutes, centrifuged and supernatant
measure to show no CR releasing. An aliquot of paraoxon was then added
resulting in final concentrations of paraoxon (1.66 – 8.28 mM). The sample was shaken for
five minutes, centrifuged, supernatant measured and particles re-suspended. This process
was repeated every five minutes for a total of 35 minutes unless otherwise noted. The
amount of CR released was determined by UV-vis based on a calibration curve.

2.3. Results
2.3.1. 31P NMR Assay of OPH Activity
Since
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P NMR can be applied to a broad spectrum of organophosphorus

compounds, it is a useful technique in comparing the activity of OPH with respect to
various substrates. Although UV-Visible spectroscopy (UV-Vis) is somewhat simpler, it
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requires the substrate to contain a chromophore, therefore it is only applicable to a subset
of compounds. Similarly, gas chromatography techniques can be a problem for low
volatility substrates. In contrast, 31P NMR can be used for a wide variety of compounds,
and the chemical shifts of the substrates and their hydrolyzed products are typically wellseparated. As has been shown in our previous experiments, the integrated areas of the
paraoxon peak at -6.45 ppm and diethyl phosphate peak at 0.80 ppm can be referenced to
an internal standard (phosphoric acid, d = 0.00 ppm, inserted into the NMR sample in a
sealed capillary), and ratios of the peak areas can then be used to give the percent
conversion of the substrate. Removal of aliquots from the enzyme-substrate reaction
solution at various points during the conversion process followed with a Lineweaver-Burk
double-reciprocal plot, which in turn is used to extract information about the activity of
OPH. In this manner, 31P NMR was used to measure OPH activity in all of our experiments.
2.3.2. Inhibition of OPH Using DEABP
To determine the type of inhibition exhibited by DEABP, free OPH (i.e. not
attached to a particle surface) was exposed to DEABP at several concentrations (16.4, 24.6
and 30.8 mM) in CHES buffer for five minutes, and then the activity of OPH toward
paraoxon was determined by 31P NMR (Figure 2.3). This was compared to the activity of
OPH in the absence of DEABP with all samples (with or without inhibitor) containing the
same amount of OPH (0.05 µg total) per sample.
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Figure 2.3: Lineweaver-Burk plots comparing competitive inhibition by tethered and free DEABP.

2.3.3. Preparation and Characterization of APMS-(s)-DEABP
Construction of the inhibitor-tethered substrate was accomplished as shown in
Figure 2.4. First, as-prepared APMS (i.e., with surfactant remaining in the pores) was
reacted with 3-aminopropyltriethyoxysilane (APTES). The surfactant was then extracted
in HCl/EtOH to open the pores of the substrate, and the primary amine was reacted with
succinic anhydride to produce a carboxylate-terminated surface. Standard peptide coupling
methodology was then used to tether DEABP to the particle surface at three different
concentrations. The resulting materials are designated APMS-(s)-DEABP (low), -DEABP
(med), and -DEABP (high).
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Figure 2.4: Synthesis of APMS-(s)-DEABP.

Thermogravimetric analysis (TGA) and N2 physisorption (Table 2.1) were used to
characterize the physical properties of the materials at each stage of modification. To
provide a basis for the calculation of the amount of organic modification of each material,
a portion of the initial batch of APMS was calcined to completely remove the surfactant.
This represented the maximum possible porosity of the material. The surface area of the
base material was modest (385 m2/g), although it was consistent with a pore diameter of
11 nm.
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Table 2.1: Physical properties of APMS and modified APMS.
Sample

SABET

Vpore

dpore

modification

(m2/g)

(cm3/g)

(nm)

(mmol/g)

APMS (calcined)

385

0.89

11

--

APMS-(s)-NH2 (extracted)

270

0.62

11

2.02

APMS-(s)-NH-COOH

233

0.54

9.1

0.61

APMS-(s)-DEABP-(low)

238

0.53

9.1

0.15

APMS-(s)-DEABP-(med)

192

0.43

8.5

0.21

APMS-(s)-DEABP-(high)

178

0.40

8.6

0.41

2.3.4. Inhibition Testing of APMS-(s)-DEABP-OPH
OPH was stirred with APMS-(s)-DEABP (low, med, and high) for 21.75 h, and
the particles were washed with CHES buffer. The amount of OPH remaining was
determined in each case by the Bradford Assay on the loading solution supernatant after
centrifugation. The amount of OPH loaded was determined from the initial Bradford Assay
on the loading solution. Each APMS-(s)-DEABP-OPH material loaded different amounts
of OPH, so adjustments were made so that each reaction contained the same amount of
OPH (0.05 µg OPH total). Inhibition tests were then performed on the basis of the amount
of immobilized DEABP, using the 31P NMR assay described above (Figure 2.3).
2.3.5. Dye Release from APMS-CR-(s)-DEABP-OPH (Single Addition)
The loading of CR within APMS-(s)-DEABP (high) varied depending on the
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material, but a typical loading was 0.168 mM dye/mg particles that resulted in a deep red
coloring (Figure 2.5). A control experiment was conducted to determine the amount of CR
that would release without OPH capping the pores. After loading, APMS-CR-(s)-DEABP
was washed extensively CHES buffer, centrifuging and re-suspending in fresh CHES each
time. It was then shaken for one hr and supernatant measured by UV-Vis for any CR in
solution. This was repeated for a total of five cycles until no further CR could be detected
by UV-Vis. The particles were now faint pink in color and were dried under vacuum and
TGA performed. There was approximately 15% of CR left in the particles that could not
be removed.
OPH was then added as described previously, to form APMS-CR-(s)-DEABPOPH. Before paraoxon was used to test the complete detection and decontamination
system, the particles were shaken for 15 minutes and the supernatant measured to ensure
no CR was releasing. A 2.5 µL aliquot of paraoxon was added, resulting in a paraoxon
concentration of 8.28 mM in the system. The concentration of dye in the supernatant was
measured every five minutes to track the release of CR after triggered release of OPH using
UV-Vis (Figure 2.5).
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Figure 2.5: Congo Red release at several concentrations of paraoxon.

This was repeated with three additional concentrations of paraoxon 6.63, 3.32 and
1.66 mM. The release profiles were plotted and fit as pseudo-first order association kinetics
to determine the initial release rates and maximum (plateau) amount of dye released (Table
2.2). A change of particle color from a deep red to a dark pink could be seen by the naked
eye (Figure 2.5).

Table 2.2: Congo Red release rates from APMS-CR-(s)-DEABP-OPH vs. [Paraoxon].
[Paraoxon]

Initial Rate

Maximum Release

(mM)

(µM/min)

(µM)

8.28

2.26

28.3

6.63

1.46

23.4

3.32

1.14

10.1

1.66

1.04

8.9
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2.3.6. Dye Release from APMS-CR-(s)-DEABP-OPH (Multiple Additions)
APMS-CR-(s)-DEABP-OPH (high) was prepared as previously described.
Compared to previous testing, more OPH (0.071 µg) was used compared to the previous
experiments. To ensure that CR was not leaching from the particles, the supernatant was
measured every four min before the first addition of paraoxon (6.63 mM in solution) after
the 12 min measurement (Figure 2.6). Subsequent measurement of the supernatant by UVVis tracked the release of CR. After the plateau (~20 min) and additional aliquot of
paraoxon (6.63 mM in solution) was added after the 28 min measurement. The supernatant
continued to be measured until the second plateau was reached (~48 min).

Figure 2.6: Congo Red release with multiple additions of paraoxon (indicated by arrow).

2.3.7. Dye Release from APMS-CR-(s)-DEABP-OPH (Recycling)
To show the recycling ability of APMS-CR-(s)-DEABP-OPH, the material was
sequentially exposed to paraoxon, 4.97 mM total in the system, with several washes with
CHES buffer between exposures. This was to insure that the only measured dye would be
released from the particles and not physisorbed (Figure 2.7). The amount of dye released
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in the second test was approximately 60% of the original amount (3.3 vs. 5.5 µM).

Figure 2.7: Sequential release of dye from APMS-CR-(s)-DEABP-OPH.

2.3.8. Dye Release from APMS-CR-(s)-DEABP-OPH (10% FBS)
APMS-CR-(s)-DEABP-OPH was prepared as previously described. After the
final wash with CHES buffer, the buffer was exchanged by washing three times with 10%
FBS. The particles were shaken and centrifuged every five minutes and the supernatant
measured by UV-Vis for 35 min to track any release of CR (less than 8 % of the total
released). A 2.5 µL aliquot of paraoxon was added after the 35 min reading, resulting in a
paraoxon concentration of 8.28 mM in the system. The concentration of dye in the
supernatant was measured every five minutes to track the release of CR after triggered
release of OPH using UV-Vis (Figure 2.8). With the addition of paraoxon, a large release
of CR was seen with a rate of 0.41 µM/min with a maximum release (plateau) of 9.5 µM.
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In comparison to previous experiments with a similar concentration of paraoxon (8.28
mM), the amount of CR red released was about one-third that of the maximum release
(28.3 µM). The final supernatant was diluted 100-fold to measure the absorbance of the
product peak (4-nitrophenol, 405 nm) to ensure that the hydrolysis of paraoxon occurred.

Figure 2.8: Dye release in 10% FBS, pH 7.4.

2.3.9. Dye Release from APMS-CR-(s)-DEABP-OPH (10% FBS) (Recycling)
After the previous release in FBS was completed, the material was washed several
times with fresh FBS to remove any remaining paraoxon, CR or OPH (previously released).
A second aliquot of paraoxon was added to give a total concentration of 0.3 mM of
paraoxon. The hydrolysis of paraoxon was tracked by UV-Vis, measuring the absorbance
of the hydrolysis product, 4-nitrophenol at 405 nm. This was done every five minutes for
30 minutes. This was then compared to a background hydrolysis of paraoxon in FBS over
the course of 90 minutes (Figure 2.9). Using a calibration curve of 4-nitrophenol, the
concentration of product in solution could be attained. The tracking of the hydrolysis was
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confirmed by recycling the material, as previously done, however using a lower
concentration of paraoxon to easily track the hydrolysis product (Figure 2.9). This was
compared to a background hydrolysis of paraoxon to ensure that conversion of the substrate
was due to OPH and not by the other proteins within the culture media. The background
conversion was minimal and appeared immediately after addition of the aliquot of
paraoxon and held constant throughout the remaining measurements.

Figure 2.9: Hydrolysis of paraoxon in 10% FBS, pH 7.4. APMS-CR-(s)-DEABP-OPH (blue);
Paraoxon only (green).

2.4. Discussion
2.4.1. Selection of Scaffold
The duality of a detection and decontamination system for organophoshates relies
on the cooperation of several elements simulataniously within a self-contained system. The
system presented has several parts that are controlled by the initial response to an
organophosphate. This triggered response controls both parts of the detetection and
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decontamination system by releasing OPH to decontaminate and the visual change to
occur. The sensitiviy and speed of the system relies on the mechanism which releases OPH
from the scaffold. This required a scaffold that could retain the activity of OPH and allow
for the addtion of a visual indicator.
The use of APMS as the solid support for the self-contained system had several
advantages. We23 and others33-35 have previously shown that the activity and thermal
stability of OPH can be altered upon immobilization within the pores of mesoporous silica.
Manipultion of the physical characteristics such as surface area and pore diameter allowed
for the tailoring of the material for surface functionalization and dye loading and release.
Larger pores (8-9 nm) permitted CR to easily enter and exit the interior volume of APMS
and the exterior surface functionalized to readily accept OPH to trap CR inside. Preparation
of the surface of APMS to temporarly hold OPH was the most important but challenging
aspect of the system. OPH had to function as the decontaminat, as well as hold back the
release of CR from the interior pore volume. The desired trigger for the release of OPH
had to be more specific than a chemical or physical change in the reaction conditions to be
a self-contained system. The temporary hold of OPH eluded to the possibility of using an
inhibitor of OPH that could be displaced by the substrate, paraoxon.
2.4.2. Selection of Inhibitor
In these studies, our goal was not to permanently immobilize OPH, but to tether
it to the surface of a porous silica nanoparticles with an inhibitor that could be displaced
upon recognition of a different organophosphorus substrate. There were several factors to
consider when selecting the inhibitor, the most important of these was the type of inibition
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it had on OPH. As the trigger, the inibitor had to be competitive to ensure that OPH would
release and in the shortest amount of time. Noncompetitive and uncompetitive inhibitors
would result in slow or no release of OPH and could decrease the rate of hydrolysis. Using
an inhibitor that was similar in structure to paraoxon and had previously been found to be
a competitive inhibitor36 was the starting point for probing its use as an immobilized
inhibitor.
We chose diethyl-4-nitrophenyl phosphate (paraoxon) and diethyl-4-aminobenzyl
phosphonate (DEABP) as the substrate and inhibitor for these experiments (Figure 2.10).
OPH rapidly reacts with paraoxon, making it easy to determine enzyme activity. DEABP
has a similar structure to paraoxon, but the p-nitrophenyl group is connected to the
phosphorus atom through a carbon atom instead of an oxygen atom. This ensures that the
hydrolytic cleavage of the p-nitrophenyl group cannot occur, although the molecule's size
is similar to paraoxon. In addition, the terminal amine allows DEABP to covalently
attached to the particle's surface with standard peptide coupling methodology. This would
allow for the temporary holding of OPH to the surface of APMS in the absence of a
compadiable substrate and then release in the prensence of paraoxon or other
organophosphate.
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Figure 2.10: Structures of the substrate and inhibitor used in these experiments.

2.4.3. Type of Inhibition
To confirm the type of inhibition DEABP has with OPH, activity of OPH
hydrolyzing paraoxon with and without DEABP were measured and plotted as
Lineweaver-Burk plot. A Lineweaver-Burk plot is a useful tool to study enzymatic
inhibition, because the effects of competitive and non-competitive inhibition produce
graphically distinct results that are easily observed. In competitive inhibition, the y
intercept (1/Vmax) remains the same in the presence of the inhibitor although the x intercept
(-1/KM) decreases because the observed binding constant of the substrate changes in the
presence of a competitive inhibitor, although at sufficiently high concentrations of
substrate the maximum velocity of the reaction remains the same. The new x intercept, 1/(1+[I]KI, where [I] = the concentration of inhibitor and KI is the dissociation constant of
the inhibitor with respect to the enzyme, is sensitive to the concentration of inhibitor.3738
(The results are shown in Figure 2.3) The y-intercept of all plots was identical, and the x
intercepts of each plot decreased as the concentration of DEABP increased. This shows
that DEABP is a competitive inhibitor of OPH, reversibly binding at the active site and
being released at higher concentrations of paraoxon.
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2.4.4. Synthesis of APMS-(s)-DEABP
The characterization of APMS-(s)-APMS was important to ensure that the design
of the scaffold not only was correct but retained the desired structural characteristics.
Characterization of the as-prepared APMS (calcined) confirmed an appropriate starting
material for the final desired APMS-(s)-DEABP. A larger pore diameter was desired to
compensate for the tightening of the pore diameter resulting from the organic
functionalization. This allowed for the final pore diameter to be large enough for the dye
to enter but more importantly allow for a faster release of dye from the interior pore volume
without restriction. The pore volume (0.89 cm3/g) of a material with this surface area and
pore diameter suggested a porous material with highly interconnected pore structure,
consistent with previous publications on APMS. This allowed for adequate volume for the
dye to be held after addition of OPH to cap the pores.
The desired surface functionalization of APMS can be seen in Figure 2.11
(Ideal). Each synthetic step factored into the number of potential inhibition sites because
the degree of each modification is dependent on the previous. The goal of the amine
addition was to thoroughly populate the surface of APMS to keep OPH on the surface of
the particle, although some diffusion of APTES within the surfactant micelles is
expected.38 Surface functionalization not only increases the potential of OPH to block the
pores of the material but increases the potential for a faster triggered release. If
functionalization occurred deeper within the mesoporous structure, the more problematic
the diffusion of substrate would be to active site of OPH (Figure 2.11 A). Functionalization
of the interior could also increase the surface charge to more positive due to the protonation
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of the amine groups. Retention of the interior volume was also necessary for maximum dye
loading needed to increase the potential amount and rate of dye released after loss of OPH.

Figure 2.11: Conceptual influences on surface functionalization and OPH loading and CR releasing.

TGA data used to show the extent of modification indicated that the external
surface was easily modified with APTES, though because the amount of modification with
succinic anhydride was less than the total amount of amines available (0.61 mmol/g versus
2.02 mmol/g), not all of the amine groups reacted with succinic anhydride. However,
coupling to DEABP appeared to be successful and controllable, with the amount of
DEABP on the surface directly related to the amount used in the synthesis (Table 2.1). The
capping of unreacted amine and succinic anhydride groups was found to not be necessary
because it did not influence the inhibition of OPH or its release, shown later in activity
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testing (Figure 2.11 B). The porosity of the material decreased after each modification, as
indicated by the decreasing SABET, Vpore, and dpore in each step. This indicated that there
was likely some modification not only of the external particle surface, but of the pore
entrances as well. However, the amount of pore modification was not significant enough
to completely close the pores, so that they could still be loaded with dye in a later step.
2.4.5. Immobilization of OPH
The immobilization of OPH onto the surface of APMS-(s)-DEABP was
controlled by many factors. An ideal material would have the maximum amount of OPH
directly proportional to the amount of DEABP on the surface because of the single catalytic
site of OPH (Figure 2.11 (Ideal)).36 Nevertheless, this does not account for other variables
that influence the amount OPH that could be immobilized. The main restriction was the
amount of OPH that could physically fit on the surface of APMS. A single OPH molecule
is approximately 6.1 nm x 8.6 nm x 5.1 nm.39 If two inhibitor molecules were at a distance
less than the smallest dimension (51Å), only one OPH would attach. This can be extended
to the other dimensions of OPH, as well as the density of inhibitor on the surface.
The packing on the surface of APMS was also influenced by the size of the
pores (8.6-9.1 nm) that were desired for the fast loading and release of dye. To ensure that
the pores would be effectively capped, two or more OPH molecules had to be in close
enough proximity (Figure 2.11 C). Without the close packing on the surface, the dye would
leach from the interior pore volume. As previously discussed, steps were taken to control
the number of inhibitor molecules available but always exceeded the amount of OPH that
attached (Table 2.3). This was to ensure that there was adequate surface coverage of OPH
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on the surface (Figure 2.11 D).
Table 2.3: Ratio of each linker on APMS surface to OPH loaded.

Linker/Sample/OPH
[NH2]

[COOH]

[DEABP]

Sample

(mM/µg OPH)

(mM/µg OPH)

(mM/µg OPH)

APMS-(s)-DEABP-(low)

2.49E-01

8.02E-02

2.66E-02

APMS-(s)-DEABP-(med)

3.68E-01

1.02E-01

5.57E-02

APMS-(s)-DEABP-(high)

2.47E-01

3.35E-02

7.25E-02

2.4.6. Inhibition Testing of APMS-(s)-DEABP-OPH
With DEABP successfully tethered to the particle surfaces, we next confirmed
that DEABP still acted as a competitive inhibitor of paraoxon after the tethering process.
The Lineweaver-Burk plot (Figure 2.3) for tethered OPH shows that DEABP continued to
act as a competitive inhibitor, because the y-intercept for the samples did not change when
the amount of DEABP changed. What is quite interesting about this plot was that although
the amount of tethered DEABP was much lower than that in tests using free DEABP (µM
here versus mM in Figure 2.3), the slopes of the lines here are significantly larger. As
described above, smaller concentrations of a competitive inhibitor are expected to show
smaller slopes. This is likely due to a concentration effect produced by immobilizing the
DEABP. When it is free, OPH must diffuse through solution between encounters with
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DEABP. However, when the DEABP is tethered to a surface, its local concentration is
much higher (Table 2.3), so the diffusion length between DEABP-OPH encounters is
much shorter, and the effective inhibition of OPH is larger. Thus, it appears that when it is
tethered to a surface, less inhibitor is required to achieve a significant inhibitory effect than
if the inhibitor were dissolved in solution.40 This is evident in the calculation of the KI
values for the free inhibitor (2.55 mM) versus immobilized (1.37 x 10-5 mM). The drastic
decrease in KI for immobilized was attributed to the immobilization of the inhibitor the
surface, locking it into a set orientation. Once OPH was in the correct orientation to bind
the inhibitor within its active site, it was held tightly. Comparing this to the free inhibitor
and free enzyme, the inhibitor was free to move about the solution allowing it to bind
weakly within the active site. This results with the free inhibitor have a much larger KI. In
terms of a triggered release system, the large slope indicates that the system is effective at
very low concentrations of substrate and is sensitive to small chan,es in substrate
concentrations.
2.4.7. Dye Selection
We tested several dyes for use in this detection system, and found that optimizing
hydrophobic and electrostatic interactions with the silica surface were critical factors.
Some dyes bound to the silica particles tightly but would not be released in sufficient
quantities once the pores were opened; others bound so loosely that not enough dye was
loaded into the particles in the first place. After multiple experiments, Congo Red (CR)
(pKa = 4.1, Figure 2.12) was selected as the detection dye because it could be loaded in
significant amounts at pH = 2.3, where it was protonated and had a neutral charge, binding
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weakly to the anionic surface of APMS.
Under the conditions used to allow the interaction of OPH with the surface-bound
inhibitor (pH ≈ 9), the surface of APMS had a negative  potential due to the deprotonation
of surface silanols.23 CR deprotonated at this pH and was now repelled from the pore
surfaces, but the OPH-inhibitor interaction occurred faster than the release of the dye, so
the majority of the dye remained trapped within the pores. Control experiments showed
the potential release of almost all of the CR with only about 15% remaining within the
particles. This was attributed to the structural characteristics of the modified material. The
interconnected pore system allows for loading deep within the pore system and pockets of
differing surface charge. This retained a small amount CR permanently but the majority
freely releasing. The particles were then washed several times to insure that any
physisorbed dye was removed. It was now ready for rapid release once OPH encountered
its substrate.

Figure 2.12: Structure and color of protonated and deprotonated forms of Congo Red.
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2.4.8. Response of APMS-CR-(s)-DEABP-OPH to Paraoxon
Several experiments were first performed to test the response of the system with
the ideal substrate, paraoxon. The release of OPH with a single, set concentration of
paraoxon showed several key benefits of the system (Figure 2.5). One of the major goals
of the system design was to visually indicate the presence of an organophosphate for ease
of use in real-world applications. A change in color by the naked eye could be easily
detected before and after exposure to paraoxon. The initial color of the material was deep
red and the release of CR after exposure to paraoxon, resulted in a material that was
noticeably lighter in color (dark pink) in a short amount of time. This allows for facile
determination of the presence of an organophosphate without instrumentation and
specialized training. The use of UV-Vis to quantify the CR release but helps to confirm not
only the response time of this visual indication, but also lends to information about the
response of the system in the presence of paraoxon.
Of the four concentrations tested (1.66, 3.32, 6.63, and 8.28 mM) a measurable
signal could already be detected after only five minutes and the maximum signal (plateau)
reached within 15-25 minutes, depending on the paraoxon concentration. This fast response
resulted from the effective combination of having a competitive inhibitor as the trigger
mechanism and the fast release of CR from the interior pore volume. This release profile
also gives insight on the mechanism of the triggered release.
At lower concentrations (1.66 to 3.32 mM), doubling the paraoxon concentration
only increases the amount of CR released from 8.9 to 10.1 µM (Table 2.1). Comparing
this to doubling the paraoxon concentration from 3.32 to 6.63 mM, the amount of CR more
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than doubles, resulting from a large burst release. Once OPH is released from the surface,
it is free to begin hydrolyzing any substrate molecules within its reach. With lower
concentrations of paraoxon, there is less substrate to initially release OPH and what does
release, quickly hydrolyzes the substrate so no further OPH is needed. With only a small
amount of OPH releasing, the potential amount of CR released was limited by the pores
that were now uncapped. With higher concentrations, there was a large amount of substrate
initially that caused a larger amount of OPH to release from the surface. This resulted in a
greater number of pores to be uncapped and resulted in a higher potential amount of CR
releasing from the particles. The amount of CR released lead to the faster plateau of the
lower paraoxon concentrations (~10 min), compared to the large initial burst but longer
time until plateau (~20-25 min) due to the CR still releasing from the larger number of
uncapped pores.
The idea that the quick release of CR at low concentrations resulted from a small
number of OPH enzymes leaving, would result with the potential to continue to release
OPH and recycle the particles. In similar fashion to testing with a single aliquot of
paraoxon, APMS-CR-(s)-DEABP-OPH was subjected to two aliquots of paraoxon while
allowing the material to reach a plateau before the addition of the second aliquot (Figure
2.6). The concentration of paraoxon (6.63 mM) added was adjusted to compensate for the
larger amount of OPH used for the experiment. A larger ratio of OPH to paraoxon of the
first aliquot allowed the equilibrium to be reached quickly (less than eight min) and the
second aliquot of the same concentration added. This took a longer time to reach plateau
(20 min) but the total amount of CR released with similar kinetics to that of the first plateau
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of about 5 µM. The slower time to reach the plateau was attributed to the smaller number
of OPH molecules on the surface of APMS-CR-(s)-DEABP-OPH after the first release, as
well as competition with released OPH. Released OPH was still viable for hydrolyzing any
further paraoxon entering the system. With the addition of more paraoxon, a temporary
increase in the total concentration paraoxon prompted additional OPH to be released. This
resulted in the increase of CR similar to that seen with previous experiments with larger
concentrations of paraoxon with a large initial burst and slower plateau. The temporary
increase in paraoxon concentration was a result of the experiment itself in which the
addition of paraoxon resulted from the plateau of CR, not the complete degradation of
paraoxon.
The recycling of APMS-CR-(s)-DEABP-OPH was such that after exposure to an
aliquot of paraoxon, the particles were washed, isolated and experiment performed again
with an additional aliquot of paraoxon (Figure 2.7). The isolation and thorough washing
of the particles ensured that the CR released would be from the second aliquot of paraoxon
and not residual CR still releasing from the pores. It also ensured that any released OPH
was fully removed from the solution and that OPH released would be only from the
paraoxon used in the second cycle. Using the low (1.66 mM) and high (8.28 mM)
concentrations of paraoxon as the boundaries, a mid-range concentration (4.97 mM) was
used to probe the recyclability and determine the type of release at this range. The initial
loading of CR in APMS-(s)-DEABP was lower than in previous samples which resulted in
a lower plateau as compared to previous samples but the design of the system was still the
same. This resulted in the expected release profile in which there was steady release of CR
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that took longer than the lower concentrations of paraoxon but did not have the burst release
as with the higher concentrations of paraoxon. This mid-range concentration also helped
to ensure that there would be OPH still left on the surface for a second use. The second
exposure to paraoxon showed a similar but slightly slower release profile. When the plateau
was reached, the second cycle still released approximately 60% of the CR that the first
cycle produced. This shows that there were still enough OPH-capped pores left after a
single cycle the material could still produce a measurable signal within a short amount of
time.
2.4.9. Selectivity of Trigger
The final set of experiments was to test the selectivity of the system in the
presence of cell culture media. Generally, FBS contributes to the cell growth and division
by providing necessary of growth factors and other proteins in culture media.41 The use of
this solution was to see if the designed triggered release system could differentiate between
the variety of other proteins in solution and the desired substrate, paraoxon. To ensure that
CR was released only by paraoxon, the APMS-CR-(s)-DEABP-OPH was first shaken and
the supernatant measured to track any release of CR from the material, which was
negligible in comparison to the release of CR after paraoxon addition (Figure 2.8).
Comparison of the ideal conditions to the cell culture media resulted in a
maximum release concentration that was about 66% lower than under ideal conditions The
ideal conditions were in CHES buffer at a more basic pH of 9.0, in which OPH is most
active for the hydrolysis of paraoxon.42 Using FBS drops the pH to physiological
conditions of pH 7.4, which lowers the rate of hydrolysis of paraoxon by OPH. This would
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lead to a change in the release pattern of OPH from the surface of APMS-CR-(s)-DEABPOPH. The other contributing influence would be the other proteins that are present within
the media. Interaction of paraoxon and APMS-CR-(s)-DEABP-OPH with these proteins
(attraction and/or repulsion) will alter the rate at which OPH is displaced and the resulting
release of CR.
Despite the lower release maximum of CR in culture media, the actual amount of
CR released was more than sufficient to be easily detected and quantified. The ability for
the system to differentiate between the desired substrate mixed within a system of a variety
of biological proteins was attributed the design of the triggered release system. Using a
competitive inhibitor based trigger allows for substrate specificity that is controlled solely
by the enzyme, drastically improving the overall efficiency of the detection and
decontamination system.
With confirmation that CR was releasing from APMS-CR-(s)-DEABP-OPH, the
last step was to confirm that the OPH that was released continued with the hydrolysis of
paraoxon. This could be easily obtained by measuring the UV-active hydrolysis product,
4-nitrophenol. The concentration of 4-nitrophenol (Figure 2.9) for the background reaction
that contained only paraoxon and FBS remained constant after an initial spike after addition
of the paraoxon. This differentiated from the sample that contained APMS-CR-(s)DEABP-OPH, in which the hydrolysis reaction was evident by the increasing
concentration of 4-nitrophenol over time. The increase in 4-nitrophenol proves that the
OPH is still actively hydrolyzing paraoxon after the triggered release from the competitive
inhibitor. This ensures that the release system does not deactivate OPH once released from
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the surface in the presence of CR and that the other proteins within the cell media do not
hinder the hydrolysis of paraoxon by OPH.
The use of this detection and decontamination system within physiological
conditions adds in multiple factors that could have negatively affected the system from
release of OPH without the substrate or prevention of CR release. The triggered release of
active OPH from the competitive inhibitor proves the high substrate specificity of the
system and the ease of the detection system by CR release shows the versatility of the
dual system, outside of ideal conditions.
2.5. Conclusions
The detection and degradation of organophosphorus compounds is an important
chemical and biochem research focus, because many of these compounds are neurotoxins
that have been used as insecticides and stockpiled as chemical warfare agents. The ideal
systems for this purpose would be triggered by the presence of the organophosphorus
compound, decontaminate it, and give a visual response of this process. The use of APMS
as the scaffold has several physical characteristics that can be tailored to support the
decontaminate (OPH) and contain the detection element (CR) as a dual functioning system.
In the system described here, the interior pore volume of APMS was loaded with
CR, and the exterior of particle was capped with an inhibited OPH that was released in the
presence of a target organophosphorus compound. Specifically, the exterior of mesoporous
silica nanoparticles was functionalized with diethyl 4-aminobenzyl phosphonate
(DEABP). The competitive inhibition of OPH, both free in solution and immobilized
DEABP, was confirmed through enzyme kinetics testing using 31P NMR. The competitive
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inhibition was used as the trigger for the release of OPH, uncapping the pores and releasing
of CR. Color change of the particles was used as visual indication, along with
quantification by UV-Vis. This system worked with not only the ideal conditions, but
within cell culture media containing a variety proteins and growth factors,
maintain the activity of OPH and detection of CR.
The use of a dual detection and decontamination system is beneficial not only in
the realm of organophosphate disposal and protection but the mechanism in which the
system is triggered. The concept of using the desired substrate as the trigger is ideal but
often difficult to obtain. Utilization of a competitive enzyme-inhibitor pair allows substrate
specificity to be built in to the trigger mechanism for a system that requires no additional
influence, chemical or physical, to give a visual response. Extension of the use of this type
of trigger can be realized in other applications in which substrate specificity is highly
desired.
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CHAPTER 3: ORGANOPHOSPHORUS DETECTION SYSTEM USING
ACETYLCHOLINESTERASE

3.1. Introduction
The detection of organophosphorus compounds has grown into a broad field, with
a variety of different ways to combat human exposure. The range of toxicity of these
compounds, and their use in a variety of applications from military conflicts to agriculture,
contribute to a range of possible exposure routes.1-8 The widespread impact of these
compounds has pushed the need for organophosphorus detection methods to be faster, and
easier for an untrained individual to use. Detection methods based on nanomaterials9-13
have been increasingly useful in optical and electrochemical sensing systems, many based
on assays measuring the activity of acetylcholinesterase (AChE).10
Organophosphorus compounds are toxic due to their irreversible inhibition of
AChE by phosphorylation.1-8 AChE is responsible for the hydrolysis of the
neurotransmitter acetylcholine (ACh), found within neural tissues. Inhibition of AChE
leads to the buildup of ACh in neuronal gaps, preventing the neurons from returning to
their resting states. 1-8, 14-15 The rate at which inhibition occurs is dependent on the chemical
nature of the specific organophosphorus compounds (Figure 3.1)16 and is also dependent
on the exposure time and concentration.
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Figure 3.1: Binding of an organophosphorus compound (sarin) in the active site of AChE. 16

The use of optical response systems, specifically those based on colorimetric
responses,3-4 have offered increased portability and ease of use with real-time detection.7,
17-26

Many of these systems rely on the measurement of activity of AChE by tracking the

hydrolysis of acetylthiocholine (AtCh) to its product, thiocholine (tCh).10, 27 Typically,
Ellman's method has been used to detect tCh due to the formation of a colored product, 2nitro-5-thiobenzoate (yellow) with the addition of 5,5-dithio-bis-(2-nitrobenzoic acid)
(Figure 3.2).27-28 One of the major drawbacks to this method is the use of additional
chemicals or materials to induce these colorimetric responses based on a secondary
response to the hydrolysis product. Many compounds can react with Ellman's reagent,
leading to false positives and reduced response signals.3-4
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Figure 3.2: Hydrolysis of AtCh by AChE and detection by the Ellman’s method to form a UV-Vis
active product 2-nitro-5-thiobenzoate (yellow).27-28

Recent advances in the use of enzyme-modified nanomaterials in clinical
diagnosis29-30 have highlighted the use of molecular recognition as an efficient way to
increase sensitivity towards a specific substrate.30-31 Control of this recognition by the use
of enzyme-specific inhibitors has been demonstrated, for example in the triggered release
of an enzyme in response to substrate exposure.32 A molecular recognition system using a
substrate-triggered release system based on the reversible inhibition of AChE would
decrease false positives, due to substrate specificity. Combining this specificity with a
direct visual response would result in a system that is easy to use with high sensitivity.
Our design of a system that combines a direct visual response with high sensitivity
began by selecting a nanoparticle scaffold. The use of a porous silica support, specifically
mesoporous silica, has several advantages. One key feature is that silica is easily modified
with organosilanes to allow for attachment of an inhibitor, tacrine, to the surface, in turn
allowing AChE to be immobilized.33-35 Tacrine has been commonly used as a competitive
inhibitor of AChE and will hold AChE only temporarily, ensuring a fast release from the
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surface of the particle. Tacrine also offers a primary amine that can be used to tether the
inhibitor to the surface.8,

36-42

Immobilization of AChE not only helps to prevent

denaturation but places the enzyme in a set confirmation to be released by substrate or
organophosphate.33,43 Prior

to

introduction

of

substrate

or

organophosphate,

immobilization of AChE on the surface will cap the pores of the mesoporous silica.
Capping allows for the containment of a dye that can act as the optical response. After
immobilization, inhibition of the AChE active site by an organophosphorus compound
interferes with the AChE-tacrine interaction, triggering the release of AChE from the
scaffold and resulting in the release of the dye (Figure 3.3). The proposed detection method
offers a primary response system in which the signal of the system is in direct response to
the substrate itself, giving high substrate specificity and limiting false positives.
While similar to the system described in Chapter 2 using OPH, AChE will not be
active after the release from the surface of the particle. Using AChE as a sacrificial enzyme
offers several advantages over the OPH based system. Sequential additions of paraoxon
resulted in OPH actively hydrolyzing after releasing from the surface. After the first
aliquot, any additional aliquots were primarily hydrolyzed by OPH free in solution. With
phosphorylation of AChE, sequential additions of paraoxon will continue to release AChE
from the surface. This resulted in testing the full concentration of each paraoxon aliquot
and testing of system to trigger a false positive. Additionally, AChE was commercially
available, and low cost, compared to OPH that requires lengthy production and
purification.
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Figure 3.3: A model of molecular recognition using inhibitor-enzyme triggered release system.

3.2. Experimental Section
3.2.1. Materials and Instrumentation
All materials were purchased from Sigma-Aldrich, VWR and Life Technologies,
unless otherwise noted. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at
100°C for 15 minutes to remove any residual water. Nitrogen adsorption and desorption
isotherms were obtained on a Micromeritics TriStar instrument. Surface areas were
measured using the Brunauer-Emmett-Teller (BET) method and pore size distributions
were calculated from a modified Kruk, Jaronic and Sayari (KJS) method using the
adsorption branch.
3.2.2. Synthesis, Functionalization and Characterization of APMS
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3.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)
APMS was synthesized as previously described.43-44
3.2.2.2. Synthesis of APMS-(s)-NH2
Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol
(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each
cycle. The degree of modification was characterized by TGA (2.02 mmol modification/g
APMS) and the physical properties characterized by nitrogen physisorption. The resulting
material was then placed under vacuum to keep dry until further modification.
3.2.2.3. Synthesis of APMS-(s)-NH-COOH
Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg)
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were
followed by drying overnight. The degree of modification was characterized by TGA
(0.606 mmol modification/g APMS) and the physical properties characterized by nitrogen
physisorption. The resulting APMS-(s)-NH-COOH was then placed under vacuum to keep
dry until further modification.
3.2.2.4. Synthesis of APMS-(s)-Tac
To APMS-(s)-NH-COOH (128 mg or 57 mg) suspended in 15 or 8 mL
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dimethylformamide (DMF), hydroxybenzotriazole (HOBt) (312, 82, or 42 mg), N, Nˈdiisopropylcarbodiimide (352, 90, or 48 mg) and 4-dimethylaminopyridine (DMAP) (16,
4, or 1 mg) were added and stirred for 1 hour. Tacrine hydrochloride (Tac) (66, 14 or 7 mg)
was then added and stirred for 19 hours. The particles were collected by vacuum filtration
and washed with DMF and MeOH and left to dry overnight. The degree of modification
(0.228, 0.281, 0.323 mmol modification/g APMS, respectively) was determined by TGA
and the physical properties characterized by nitrogen physisorption. The resulting APMS(s)-Tac was then placed under vacuum to keep dry until further modification.
3.2.2.5. Determination of [AChE]
Free AChE concentrations and amounts of AChE immobilized onto APMS-(s)Tac were calculated using a PierceTM BCA protein assay kit using a standard bovine serum
albumin (BSA) calibration curve (reference in text). Triplicate samples measured for the
standard curve.
3.2.2.6. Synthesis of APMS-(s)-Tac-AChE
An acetylcholinesterase (AChE) stock (0.5 units/mL) in phosphate buffer (100
mM, pH = 7.3) was diluted (195 µL AChE stock in 155 µL phosphate buffer). 280 µL of
this solution was added to 2.5 mg APMS-(s)-Tac and shaken for 24 hours. The sample was
centrifuged, supernatant removed and immobilized AChE determined. The particles were
washed with phosphate buffer (3X) and re-suspended in the appropriate amount of
phosphate buffer for kinetics testing.
3.2.3. Measurement of Enzymatic Activity
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3.2.3.1. Degradation of AtCh by Free AChE
To phosphate buffer (100 mM, pH = 7.3, 747.5 µL), Ellman’s reagent (20 µL)
(reference in main text) and AChE (24.7 µg/mL, 5 µL, 6.8 ng per sample) were added. An
acetylthiocholine stock (AtCh) (2.5 µL, 75 mM in deionized water) was prepared and an
aliquot added to give varying concentrations of AtCh (0.24 - 1.38 mM) in the solution and
the time recorded. The sample was shaken for 4 minutes at which time AChE was
denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each sample was ran in triplicate
and the absorbance peak of 2-nitro-5-thiobenzoate at 412 nm and the extinction coefficient
(14250 M-1 cm-1) were used to determine kinetics.
3.2.3.2. Inhibition of Free AChE by Tac
To phosphate buffer (100 mM, pH = 7.3, 747.5 µL), AChE (18.9 µg/mL, 5 µL,
6.8 ng per sample) was added. A stock solution of Tac (9.34 µM) was prepared and an
aliquot added to give varying concentrations of Tac (0.06, 0.12 and 0.30 mM) in the
reaction. The sample was shaken for five minutes and then from an AtCh stock (75 mM
in deionized water), an aliquot was added to give varying concentrations of AtCh (0.24 0.95 mM) in the reaction and the time recorded. The sample was shaken for 6-12 minutes
at which time AChE was denatured using sodium dodecyl sulfate (0.3 M, 50 µL). Each
sample was run in triplicate and were used to determine kinetics using the Ellman’s
method.27
3.2.3.3. Degradation of AtCh Using APMS-(s)-Tac-AChE
To phosphate buffer (100 mM, pH = 7.3, 1121 µL), APMS-(s)-Tac-AChE (6.8 ng
AChE total) was added. From an AtCh stock (75 mM in deionized water), an aliquot was
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added to give varying concentrations of AtCh (0.24 - 0.95 mM) in the reaction and the time
recorded. The sample was shaken for 10 minutes and the entire reaction mixture was
filtered using a 0.2 µm nylon membrane (25 mm) syringe filter. Each sample was ran in
triplicate and were used to determine kinetics using the Ellman’s method.
3.2.4. Congo Red Loading and Release Using AChE-Tethered Particles
3.2.4.1. Loading of Congo Red (APMS-CR-(s)-Tac)
Congo Red (CR) (31.4 mg) was dissolved in a citrate buffer (5 mL, 0.01 M, pH
3.98) to make a CR stock. In a typical loading procedure, APMS-(s)-Tac (4.2 mg) was
suspended in a CR stock (3 mL, 9.01 mM) and shaken (20 hr). The sample was centrifuged
and the supernatant measured by UV-Vis to determine the amount of CR loaded. The
material was washed once with citrate buffer then with phosphate buffer (100 mM, pH =
7.3) to prepare for loading with AChE.
3.2.4.2. Loading AChE (APMS-CR-(s)-Tac-AChE)
A typical loading required 4.2 mg APMS-CR-(s)-Tac suspended in 950 µL
phosphate buffer (100 mM, pH = 7.3), to which 250 µL AChE (499 µg/mL) was added and
placed on a rotating platform for 24 hours. The sample was centrifuged, supernatant
removed and immobilized AChE determined by the BCA assay. The particles were washed
with phosphate buffer until all non-encapsulated CR was removed. The particles
were then re-suspended in the appropriate amount of phosphate buffer for kinetics testing.
3.2.4.3. Release of Congo Red from APMS-CR-(s)-Tac-AChE
In a typical reaction, phosphate buffer (100 mM, pH = 7.3, 950 µL) and APMS(s)-Tac-AChE (25.5 µg AChE total) were added. Testing using alternative solutions
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included using cell culture media (10% Fetal bovine serum (FBS) in Dulbecco’s Modified
Eagle Medium (DMEM) (no phenol red, glutamine or glucose, pH 7.4)) and 100% Human
serum (male, AB plasma). Exchange of the AChE loading buffer with either FBS or human
serum was performed by centrifuging and re-suspending the particles 3X to ensure full
exchange into the new solution. A typical reaction sample, unless noted otherwise, was
shaken for 15 minutes, centrifuged and supernatant measure to ensure no CR was releasing.
An aliquot of substrate (paraoxon or AtCh) was then added, adjusting this volume for the
desired final concentration in solution. This was shaken for five minutes, centrifuged,
supernatant measured and particles re-suspended. This process was repeated every five
minutes for 60 minutes unless otherwise noted. The amount of CR released was determined
by UV-Vis based on a calibration curve.

3.3. Results
3.3.1. Ellman’s Method: Assay of AChE Activity
Ellman’s method has been widely used as a colorimetric method for the
determination of AChE activity by quantifying the amount of tCh produced by the
hydrolysis reaction of AtCh. The thiol containing product (tCh) reacts with the Ellman’s
reagent, 5,5ˈ-dithio-bis-(2-nitrobenzoic acid) (DTNB), to produce 2-nitro-5-thiobenzoate
(TNB) (Figure 3.2). This can be measured using UV-Visible spectroscopy (UV-Vis) at
412 nm with a known extinction coefficient of 14250 M-1 cm-1 in phosphate buffer (pH
7.4, 25 °C) (Figure 3.4).27-28 Removal of aliquots from the enzyme-substrate reaction
solution at specific time points during the conversion process allows for the data to be used
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in a Lineweaver-Burk double-reciprocal plot, which in turn is used to extract information
about the activity of AChE.

Figure 3.4: Absorption spectra of 2-nitro-5-thiobenzoate.

3.3.2. Inhibition of Free AChE Using Tac
To determine the type of inhibition exhibited by Tac, free AChE (i.e. not attached
to a particle surface) was exposed to Tac at several concentrations in phosphate buffer. The
activity of AChE with AtCh in the presence of Tac was determined by Lineweaver-Burk
plots from UV-Vis (Figure 3.5). The activity of AChE in the absence of Tac was then
determined in a similar manner; the same amount of AChE (6.8 ng) was used in all
experiments.
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Figure 3.5: Lineweaver-Burk plots comparing inhibition of free vs. immobilized Tac.

3.3.3. Preparation and Characterization of APMS-(s)-Tac
Construction of the inhibitor-tethered scaffold was accomplished as shown in
Figure 3.6. First, as-prepared APMS (i.e., with surfactant remaining in the pores) was
reacted with 3-aminopropyltriethyoxysilane (APTES). The surfactant was then extracted
in a solution of HCl/EtOH, to open the pores of the scaffold. The primary amine was
reacted with succinic anhydride to produce a carboxylate-terminated surface. Activation of
the carboxylic acid using N, Nˈ-diisopropylcarbodiimide, followed by the addition of
HOBt for generation of an active ester for efficient acylation of amino groups.45 This was
used to tether Tac to the particle surface at three different concentrations. The resulting
materials are designated APMS-(s)-Tac (low), -Tac (med), and -Tac (high); having 0.23,
0.28, and 0.32 mmol tacrine per gram of APMS, respectively.
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Figure 3.6: Synthesis of APMS-(s)-Tac.

Thermogravimetric analysis (TGA) and N2 physisorption (Table 3.1) were used
to characterize the physical properties of the materials at each stage of modification. To
provide a basis for the calculation of the amount of organic modification of each material,
a portion of the initial batch of APMS was calcined to completely remove the surfactant.
This represented the maximum possible porosity of the material. The surface area of the
base material was modest (385 m2/g), although it was consistent with a pore diameter of
11 nm.
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Table 3.1: Physical properties of APMS and modified APMS.
Sample

SABET

Vpore

dpore

modification

(m2/g)

(cm3/g)

(nm)

(mmol/g)

APMS (calcined)

385

0.89

11

--

APMS-(s)-NH2 (extracted)

270

0.62

11

2.02

APMS-(s)-NH-COOH

233

0.54

9.1

0.61

APMS-(s)-Tac-(low)

219

0.52

9.1

0.23

APMS-(s)-Tac-(med)

210

0.50

9.1

0.28

APMS-(s)-Tac-(high)

224

0.53

9.1

0.32

3.3.4. Inhibition Testing of APMS-(s)-Tac-AChE
AChE was stirred with APMS-(s)-Tac (low, med, and high), and the particles
were washed to ensure removal of unbound AChE. The amount of AChE loaded was
determined by BCA assay46 that was performed before and after loading. Each APMS-(s)Tac-AChE (low, med, high) material loaded different amounts of AChE (3.2, 1.2, 5.0 μg
AChE/APMS (mg), respectively) so adjustments were made by re-suspending the APMS(s)-Tac-AChE in phosphate buffer and adding an aliquot of this suspension to the reaction
solution so that each reaction sample contained the same amount of AChE (6.8 ng AChE
total). Inhibition tests were then performed using the Ellman’s method assay described
above.
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3.3.5. Loading of Congo Red in APMS-(s)-Tac
The loading of Congo Red (CR) within APMS-(s)-Tac (high) varied depending
on the sample, but a typical loading was 1.3 mM dye/mg particles, resulting in a deep red
nanoparticle, APMS-CR-(s)-Tac (Figure 3.7). A control experiment was conducted to
determine the maximum amount of CR that would release without AChE capping the
pores. In this experiment, APMS-CR-(s)-Tac was washed six times with phosphate buffer,
centrifuging and re-suspending in fresh phosphate buffer each time. It was then shaken for
one hour in phosphate buffer and supernatant measured by UV-Vis to determine the
amount of CR in solution. This was repeated for a total of five cycles until no further CR
could be detected by UV-Vis. The particles were now faint pink in color and were dried
under vacuum and TGA performed. Approximately 1% of CR could not be removed from
the particles.
3.3.6. Dye Release from APMS-CR-(s)-Tac-AChE (Single Addition)
After this experiment, AChE was attached to fully CR-loaded nanoparticles
through the tacrine inhibitor to form APMS-CR-(s)-Tac-AChE. Experiments were then
performed to confirm that tacrine was inhibiting AChE through its active site. Prior to the
addition of AtCh, the particles (4.1 mg APMS-CR-(s)-Tac-AChE in 659 μL phosphate
buffer) were shaken for 15 minutes, and the supernatant measured to ensure no CR was
releasing. An aliquot of AtCh was then added, resulting in an AtCh concentration of 1.70
mM. The concentration of dye in the supernatant was measured every five minutes to track
the release of CR after detachment of AChE from the nanoparticle surface using UV-Vis
(Figure 3.7).
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Figure 3.7: Congo Red release at several concentrations of AtCh.

This was repeated with three additional concentrations of AtCh (1.27, 0.78 and
0.36 mM). The release profiles were plotted and fit as pseudo-first order association
kinetics (Rate = kˈ[A]) to determine the initial release rates and maximum (plateau) amount
of dye (Table 3.2). Pseudo-first order (A + B  P) has a second order reaction (Rate =
k[A][B]) where [B] is has a high enough concentration that when the reaction goes to
completion, the [B] remains constant (independent of [A]), defining it as kˈ = k[B]. For
these experiments, AtCh has to first displace AChE and then CR must leave the interior of
the particle. Similar to the pseudo-first order, the initial release of AChE can be defined as
[B], releasing a set amount of AChE, independent of the amount of CR in the particle. The
release of CR can be defined as [A], giving a pseudo-first order rate equation. A change of
particle color from a deep red to a pink color could be seen by the naked eye (Figure 3.6).
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Table 3.2: Congo Red release rates from APMS-CR-(s)-Tac-AChE vs. [AtCh].
[AtCh]

Initial Rate

Maximum Release

(mM)

(µM/min)

(µM)

1.70

0.063

0.68

1.27

0.055

0.42

0.78

0.044

0.32

0.36

0.033

0.25

3.3.7. Dye Release from APMS-CR-(s)-Tac-AChE (Multiple Additions)
APMS-CR-(s)-Tac-AChE (high) was prepared and washed as previously
described. AtCh was then added (0.781 mM in solution) and the concentration of CR in
the supernatant was measured every five minutes to track the release of CR (Figure 3.8).
After a plateau was reached (~20 min), an additional aliquot of AtCh (0.781 mM in
solution) was added. The supernatant continued to be measured until the second plateau
was reached (~50 min). This process was repeated with a third aliquot of the same
concentration of AtCh and the supernatant measured until a third plateau was reached (~75
min).
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Figure 3.8: Congo Red release with multiple additions of AtCh (indicated by arrow).

3.3.8. Dye Release from APMS-CR-(s)-Tac-AChE (Recycling)
To show the recycling ability of APMS-CR-(s)-Tac-AChE, the material was
sequentially exposed to AtCh, 0.36 mM total in solution, with several washes with
phosphate buffer between cycles. This was to ensure that any release of CR or AChE was
removed before the second cycle (Figure 3.9). The amount of dye released in the second
test was approximately 56% of the original amount (0.14 vs. 0.25 µM).
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Figure 3.9: Sequential release of dye from APMS-CR-(s)-Tac-AChE.

3.3.9. Dye Release from APMS-CR-(s)-Tac-AChE (Solution Comparison (AtCh))

The triggered release system was also tested in protein-containing solutions.
Attachment of AChE was accomplished using the procedure described above to form
APMS-CR-(s)-Tac-AChE. Three separate experiments were conducted in phosphate
buffer, 10 % fetal bovine serum (FBS), and human serum. The particles used in the human
serum were allowed to reach an equilibrium with any proteins binding to the surface of
APMS-CR-(s)-TAC-AChE by shaking the particles for 60 minutes in human serum.
Prolonged shaking to reach equilibrium for the particles in FBS was reduced to 15 minutes
to reach equilibrium, resulting from the smaller concentration of proteins in solution. A
single aliquot of AtCh (8.2 mM total in solution) was added and the release of CR tracked
by UV-Vis (Figure 3.10). The release of CR was measured every five minutes until a
plateau was reached, and then the experiment was terminated. Addition of the Ellman’s
reagent to the final supernatant for the phosphate buffer sample and subsequent
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measurement by UV-Vis ensured that the hydrolysis of AtCh had occurred. The initial
release rates and maximum release amounts were: phosphate buffer (0.136 mM/min, 1.35
mM), FBS (0.105 mM/min, 0.96 mM) and human serum (0.074 mM/min, 0.87 mM).

Figure 3.10: Dye release comparison in different solutions with set [AtCh].

3.10. Dye Release from APMS-CR-(s)-Tac-AChE (Solution Comparison (Paraoxon))
Testing the triggered release system in alternative solutions using paraoxon
instead of AtCh was performed. Attachment of AChE was accomplished through the
previously described procedure to form APMS-CR-(s)-Tac-AChE. The same experimental
procedure as described in section 3.3.9 was followed with each alternative testing solution
using a single aliquot of paraoxon (8.2 mM total in solution), and the release of CR was
tracked by UV-Vis (Figure 3.11). The amount of CR released into the solution was
measured every five minutes until a plateau was reached, and then the experiment was
terminated. The initial release rates and maximum release amounts were: phosphate buffer
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(0.455 mM/min, 2.90 mM), FBS (0.246 mM/min, 1.76 mM) and human serum (0.154
mM/min, 1.67 mM). The supernatant from the phosphate buffer solution was removed and
AChE actitivty tested to confirm the inhibtion by paraoxon. The Ellman’s method was
perfromed with the addtion of AtCh (0.69 mM in solution) and DTNB and shaken for 30
minutes. This resulted with no measurable production of 2-nitro-5-thiobenzoate,
confirming the inhibition of AChE. For FBS and human serum solutions, the Ellman’s
method resulted in false positives due to the DTNB reacting with thiol-containing proteins
present in solution.

Figure 3.11: Dye release comparison in different solutions with set [Paraoxon].

3.4. Discussion
3.4.1. Selection of Scaffold
The detection system requires the cooperation of several components within close
proximity of each other to act as a triggered release system. The use of porous silica allows
the structural integrity of the detection device to be retained, allowing the scaffold to
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withstand repeated washing cycles and re-cycling of the material without deteriorating.
Mesoporous silica offers a way to control important structural characteristics such as
surface area and pore diameter and allows for a large interior pore volume to retain a dye.
The surface of mesoporous silica can be readily modified with various functional groups,
tailoring the material to allow for attachment of the desired inhibitor.
3.4.2. Selection of Inhibitor
The selection of a proper inhibitor relies on several factors, which must be
considered to allow for the system to function properly. These factors consist of the nature
of inhibition, ability to immobilize the inhibitor on the scaffold, and nature of inhibition
after immobilization. With these in mind, the starting point of the selection process was to
find an inhibitor that was competitive to allow for only a temporary tether of the enzyme
within the AChE active site. While paraoxon is not the substrate for AChE, paraoxon will
phosphorylate the active site of AChE, disrupting the inhibitor-enzyme interaction.
Reversible inhibition of AChE has been used to treat neurodegenerative disorders
such as Alzheimer’s disease (AD), which is caused by a reduced number of cholinergic
neurons and ACh.8, 47 Reversible inhibitors can be separated into two categories dependent
on their role in substrate conversion. Competitive inhibitors compete with the substrate for
the active site of the enzyme, whereas non-competitive inhibitors can react with the
substrate-enzyme complex, binding to a site separate from the active site, decreasing the
conversion rate to product.48 Examples of both types of inhibitors have been studied to find
their interaction with the AChE active site and how this determines the nature of their
inhibition.8
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AChE has an elongated pocket in which the catalytic anionic site (CAS) is located
at the base with an additional peripheral anionic site (PAS) located at the mouth of the
pocket (Figure 1.11). Both of these sites have shown to play a crucial role in determining
the type and degree of inhibition. For example, the AChE inhibitor donepezil binds to the
PAS, resulting in non-competitive inhibition, while tacrine binds to the CAS, resulting in
competitive inhibition at high concentrations.8, 36-42 It is also possible to block both the PAS
and CAS with a dual binding inhibitor using a bivalent ligand. The use of two tacrine
molecules, bound by a polymethylene spacer, made contact with the CAS and PAS (Figure
3.12).36

Figure 3.12: AChE inhibtiors.8, 36-42

For the nanoparticle-based triggered release system, binding of the inhibitor to the
CAS must occur for competitive inhibition, resulting in the fast release of AChE from the
surface of the silica. Tacrine has been commonly used as a competitive inhibitor of AChE
and offers functional groups that can be used to tether the inhibitor to the surface.

8, 36-42

Immobilizing AChE allows the pores of the scaffold to be capped, retaining the loaded dye
and acting as the triggered release system. The attachment of tacrine can be accomplished
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through a peptide bond with the available primary amine on the center ring (Figure 3.6).
To ensure interaction with the CAS, the chain length from the silica surface to the
end of the inhibitor must be at least 14 Å to reach within the deep pocket of the AChE
active site.36 Without this minimum chain length, interaction with the PAS could result,
leading to non-competitive inhibition. In our case, after the peptide bond formation, the
chain length could be estimated to be around 19 Å using average bond lengths for C-C (154
pm) and C-N (147 pm) bonds molecular modeling would be needed for maximum
accuracy.49
3.4.3. Type of Inhibition
The last point to address was whether tacrine maintained its role as a competitive
inhibitor after immobilization. Enzyme inhibition can be determined through a variety of
methods by comparing the activity of the free enzyme with and without the inhibitor. A
Lineweaver-Burk plot is a useful tool to study enzymatic inhibition, because the effects of
competitive and non-competitive inhibition produce graphically distinct results that are
easily observed. In competitive inhibition, the y intercept (1/Vmax) remains the same in the
presence of the inhibitor and the x intercept (-1/KM) decreases. This is a result of the
observed binding constant of the substrate changing in the presence of a competitive
inhibitor, although at sufficiently high concentrations of substrate the maximum velocity
of the reaction remains the same. The new x intercept, -1/(1+[I]KI), where [I] = the
concentration of inhibitor and KI is the dissociation constant of the inhibitor with respect
to the enzyme, is sensitive to the concentration of inhibitor.48 The comparison of AChE
activity with and without tacrine are shown in Figure 3.5. The y intercept of all plots were
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identical, and the x intercepts of each plot decreased as the concentration of tacrine
increased. Lower concentrations of tacrine were tested but resulted in non-competitive
inhibition, as previously found in literature.41, 50-52 To ensure competitive inhibition, a
higher ratio of inhibitor to AChE was maintained. Confirmation of competitive inhibition
of tacrine free in solution under the set conditions allowed for a standard to which the
immobilized inhibitor could be compared.
3.4.4. Synthesis of APMS-(s)-Tac
The design of the scaffold and its functionalization, as previously discussed,
played an important role in trying to maintain the competitive inhibition of tacrine with
AChE. Calcined APMS was first characterized to ensure that the starting material was
adequate to not only allow for addition of the organic moieties but also to allow for loading
of dye (Table 3.1). A large pore diameter (~1 nm) and large pore volume for the final
functionalized material were both desired. This results in easier loading and release of dye
from the interior pore volume. The large pore volume allowed the amount of dye that would
release once AChE was displaced to be maximized. Analysis of the pore volume (0.89
cm3/g) of a material with this surface area and pore diameter suggested a porous material
with highly interconnected pore structure, consistent with previous publications on
APMS.6, 53 A pore volume of this size was suitable to continue with surface modification.
Next, the surface functionalization steps to add the inhibitor to APMS were
performed (Figure 3.6). The first synthetic step was the attachment of the primary amine
to the surface. Limiting the aminosilane functionalization primarily to the external particle
surface was controlled by using as-prepared APMS, in which the surfactant was still intact,
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preventing modification of the pore surfaces. AChE was required to be on the surface not
only to block the pores, but also to allow the substrate easier access to the CAS. Removal
of the surfactant following functionalization with the primary amine, confirming that
modification hard primarily taken place on the external surface. A short functionalization
time also helped to control the location of the amine, although some diffusion of APTES
within the surfactant micelles is expected.54
Thorough population of the surface with the amine (2.02 mmol/g) allowed the
carboxylic acid functionality to be added. The extent of modification with succinic
anhydride was less than with the amine addition (0.61 mmol/g versus 2.02 mmol/g)
resulting with some unreacted amine groups, which was expected. The last
functionalization step was the controlled addition of tacrine to the surface at several
concentrations by adjusting the amount of tacrine available during the peptide coupling
(Table 3.1). The coupling procedure begins with the activation of the carboxylic acid with
the introduction of the diisopropylcarbodiimide to form the highly reactive o-acyl-urea. To
prevent racemization, HOBt reacts with the o-acyl-urea to form an active ester.
Introduction of tacrine at set concentrations limits the amount that can be immobilized
through the peptide bond formation.45 The resulting mixed surface of unreacted amines,
carboxylic acid groups, and tacrine did not appear to influence inhibition testing with
AChE (Figure 3.13). Porosity was retained throughout the modification process,
determined by analysis of the SABET, Vpore, and dpore after each step (Table 3.1). A decrease
in each of these physical parameters is typical of functionalization in which small amounts
of silane may modify the mouths of the pore. Increasing the length of the linker to the
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tacrine would decrease the porosity even further. Despite the decrease, the final porosity
and pore volume was sufficient to retain the dye and allow for the capping by AChE.

Figure 3.13: Conceptual influences on surface functionalization and AChE loading and CR releasing.

3.4.5. Immobilization of AChE
The immobilization of AChE onto the surface of APMS-(s)-Tac was controlled
by many factors resulting from the physical characteristics of AChE in relation to the
surface functionalization of APMS. For example, a comparison of the amount of AChE
loaded to the amount of tacrine that was present on the surface showed that excess tacrine
was always present. For example, even at the lowest immobilized tacrine concentration,
APMS-(s)-Tac (low) had approximately 0.014 mM tacrine per mM AChE. Comparison of
these concentrations showed that the packing of AChE on the surface was not limited by
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the number of available tacrine molecules. This would result in a surface that had not only
unreacted amine and carboxylic acid groups but free tacrine (Figure 3.13 A). The high
ratio of tacrine to AChE could result from the relative size of AChE (9.3 nm x 8.1 nm x
9.7 nm).55 If two or more inhibitor molecules were less than 81 Å apart, then AChE would
bind to one of them and cover the others. The benefit of having an excess of available
inhibitor was to increase the likelihood of tight packing on the surface, allowing the pores
to be capped most effectively. The large size of AChE in comparison to the average pore
diameter (~ 9.1 nm) also resulted in the possibility that only one AChE would be needed
to cover a pore (Figure 3.13 C). Two or more AChE could also cover a pore (Figure 3.13
B); the difference between these two scenarios was controlled by the distance between
pores and the density of AChE packing on the surface. The ability for a single or multiple
AChE to cap a pore further increases the potential for retaining the dye.
3.4.6. Inhibition Testing of APMS-(s)-Tac-AChE
For the triggered release system to be functional, the immobilized tacrine had to
continue to perform as a competitive inhibitor. As in the case of free tacrine and AChE,
APMS-(s)-Tac-AChE kinetics were evaluated using a Lineweaver-Burk plot (Figure 3.5).
Intersection of the three APMS-(s)-Tac-AChE samples at the same point on the y-axis
found with and without tacrine confirms that tacrine is still a competitive inhibitor after
immobilization. The concentration of immobilized tacrine was calculated based on the
amount of AChE needed (6.8 ng per sample) for each of the sample. The concentrations of
tacrine do not directly correspond to the slopes of the lines such that the higher the
concentration of inhibitor, the steeper the slope. This resulted from the variation in AChE
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Loaded, 3.2, 1.2, 5.0 μg AChE/APMS (mg) for each of the materials, APMS-(s)-Tac (low,
med, high), respectively. However, the slope increase corresponded directly to the starting
material concentration of immobilized inhibitor, from 0.23 to 0.32 mmol/g APMS. The
larger slope using immobilized AChE compared to free AChE can be attributed to a higher
localized concentration of tacrine on the surface compared to free in solution.56 This helped
to ensure the ratio of tacrine to AChE was large enough to force competitive inhibition
over non-competitive inhibition. In terms of a triggered release system, the large slope
indicates that the system is effective at very low concentrations of substrate and is sensitive
to small changes in substrate concentrations.
3.4.7. Dye Selection
Congo Red (CR) (pKa = 4.1, Figure 3.14) was selected as the dye in this system
because it could be loaded in significant amounts at pH = 2.3, above the isoelectric point
(IEP = ~ pH = 2) of SiO2. The majority of the surface of silica nanoparticles at all pHs
contains ≡Si-O-Si≡ and ≡Si-OH. At a pH below the IEP of silica, the surface has an overall
positive charge, with the surface containing protonated silanols (≡Si-OH2+) where it will
remain mainly deprotonated. At a pH above the IEP of silica, the surface has an overall
negative charge, with the surface containing deprotonated silanols (≡Si-O-).57 This allowed
for weak interaction with the anionic surface of APMS. During the release experiments,
the use of a basic buffer (phosphate buffer, pH = 7.3) results in a deprotonation of the
surface silanols and the surface of APMS will have a negative  potential.53 This change
in buffer results in the deprotonation of CR, repelling it from the pore surface and releasing
the dye. Although the pore capping step was performed above pH = 4.1, the interaction of
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AChE with the surface bound tacrine occurred with sufficient speed that the majority of
the dye remained within the pores. In control experiments, it was found that the only about
1% of the loaded CR remained within the particles. APMS has a highly inter-connected
pore structure, which allows dye to be loaded deep within the nanoparticles. The native
and modified material may have pockets of different surface charge that could also trap
CR. Despite this, the majority of dye could be released to give direct visual indication of
the AChE reaction.

Figure 3.14: Structure and color of protonated and deprotonated forms of Congo Red

3.4.8. Release of CR from APMS-CR-(s)-Tac-AChE
The release of CR using a single aliquot of AtCh at several concentrations allowed a release
profile to be constructed under ideal conditions. Quantification of CR release provided
104

confirmation of the visual change and also provided information about the kinetics of the
system.

Figure 3.15: Michaelis-Menten kinetics of CR release.

If the rate of dye release is sufficiently rapid, it should reflect enzymatic kinetics,
following a Michaelis-Menten model.48 Indeed, plotting the rate of CR release versus
substrate concentration showed a graph typical of Michaelis-Menten kinetics (Figure
3.15). This implies that as the substrate concentration increases, the rate of CR release will
also increase until the point of saturation by the substrate. This confirms that the process
of dye release and the process of substrate recognition are independent of each other.
Calculation of kinetic constants from this plot gave kcat/Km = 3.73 x 104 M-1s-1, which is
comparable to the actual value of 2.72 x 102 M-1s-1 measured by Ellman's method.
Figure 3.8 shows that it was possible to release more CR after the first addition
(0.78 mM in solution) of AtCh by adding more AtCh after the rate of CR had plateaued.
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However, the amount of CR release is substantially lower, because free AChE
now competes for the AtCh with bound AChE. After the first plateau, an additional aliquot
(0.78 mM in solution) of AtCh showed an increase of CR until a second plateau within a
similar 20-minute window and a measurable signal within five minutes. Repeating this a
third time (0.78 mM in solution) resulted in a similar result. After this point, additional
aliquots did not give an increased CR signal. The large amount of free AChE was
hydrolyzing the substrate faster than the amount of time it took AtCh to reach the bound
AChE.
On the other hand, isolation and resuspension of the particles between the first
and second additions of AtCh should eliminate cross-reaction with free AChE. This was
indeed the case for the second cycle with a slightly lower maximum release amount
(Figure 3.9). The smaller amount of CR released was consistent with a smaller amount of
AChE on the surface and a smaller amount of CR still remaining in the material. These two
different experiments (sequential addition and recycling) showed that the material retained
its structural integrity after multiple substrate additions and can be washed and recycled
for further use.
Extensive testing of the triggered release system using AtCh showed the stability
of the inhibitor-enzyme interaction. To use this triggered-release system as a detection
system for organophosphates, the same must hold true. In the presence of an
organophosphate, such as paraoxon, a serine residue within the active site of AChE is
phosphorylated.58 The interaction of tacrine with the active site of AChE should therefore
be disrupted by the introduction of paraoxon, causing the release of AChE from the surface
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of APMS-(s)-Tac-AChE. The release of CR from the interior pore volume could then be
tracked in similar fashion as with AtCh.
CR release kinetics could be used to compare the sensitivity of the AChE release
in the presence of AtCh versus paraoxon. The initial release rate and maximum release of
CR in phosphate buffer with AtCh (Figure 3.10; 0.136 mM/min and 1.35 mM) compared
to the addition of paraoxon (Figure 3.11; 0.455 mM/min and 2.9 mM) was attributed to
difference in the mechanism of AChE release. The hydrolysis of AtCh by AChE (1.6 x 104
M-1min-1) was lower than the inhibition of AChE with paraoxon (2.9 x 105 M-1min-1).59
This results in a faster rate of release of AChE from the surface and a larger release of CR
with the inhibition of AChE. The release of CR using paraoxon confirms the ability of this
system to work not only with a substrate but with an organophosphate to allow for direct
detection.
3.4.9. Selectivity of Trigger
In phosphate buffer, the triggered release system worked effectively to release
CR. Moving away from this controlled environment to a solution containing other
molecules and proteins allowed for the selectivity of the trigger to be tested. Cell culture
media, 10% FBS, contained a small amount of proteins and other growth factors60 that
could potentially interfere with substrate selectivity or release of AChE.
Simple exposure of APMS-CR-(s)-Tac-AChE to 10% FBS showed no release of
CR. This showed that the presence of other molecules did not interfere with the
immobilization of AChE with tacrine. The release of CR from APMS-CR-(s)-Tac-AChE
did not occur until after the addition of AtCh (Figure 3.10) or paraoxon (Figure 3.11). The
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release of CR using either of the substrates resulted in a slightly decreased initial release
rate and maximum release amount than under the ideal conditions using only phosphate
buffer. The lower rates were expected due to the interference with other proteins within the
reaction mixture that will limit the diffusion rate as well as possible interactions with the
substrate. In the case of paraoxon, phosphorylation of other proteins can occur, decreasing
the actual amount of paraoxon reaching the particles. To ensure that the release of CR was
due to the addition of substrate, in the case of AtCh, addition of Ellman’s reagent to the
supernatant showed hydrolysis of AtCh. This shows that not only was the system able to
release AChE in a complex mixture of other proteins, but specifically releases it when the
substrate is present.
Taking the selectivity of this system a step further and increasing the potential for
premature triggered release, a similar experiment was performed but using 100 % human
serum. The use of 100% serum increases the concentration of proteins to 4.0-9.0 g/dl. With
a larger number of proteins in solution, an equilibrium with any binding proteins was
allowed to be reached. This ensured that competition between substrate and binding
proteins did not occur when forming the corona, a layer of proteins electrostatically bound
to the surface of the particle.61 Despite the large increase in concentration of free proteins
and bound proteins, the system still showed CR after the addition of AtCh (Figure 3.10)
or paraoxon (Figure 3.11). The rates of release and overall maximum release amount were
slightly higher than FBS but remained less than with the ideal conditions. The lower release
of CR in FBS was attributed to the lower amount of CR loaded in the sample (0.65 mM
dye/mg particles) compared to testing in human serum and phosphate buffer (0.86 mM/mg
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particles). The ability of this system to release CR within a system flooded with other
proteins shows the selectivity that is afforded through an enzyme-inhibitor pair and creates
an effective detection system.

3.5. Conclusions
The need for an efficient and easily accessible detection system for
organophosphorus compounds have expanded this area of research into the need for a
system in which no additional external influence is needed other than the neurotoxin itself.
The use of mesoporous silica nanoparticles offers a unique scaffold in which the entire
detection system can be retained. In this system, the exterior modification using an inhibitor
allows an enzyme-inhibitor pairing to act as the trigger and cap of the material. The loading
of the interior pore volume with a dye is held intact by the cap and its release was the direct
result of the triggered release of the enzyme.
In the detection system described here, the exterior of APMS was functionalized
with the competitive inhibitor (tacrine) that was confirmed both free in solution and when
immobilized. This was followed by loading the interior pore volume with CR and
subsequent inhibition of AChE to tether it to the surface. AChE remained inhibited until
the addition of substrate or organophosphorus compound. Addition of either of these
substrates prompted the displacement of AChE and allowed for the release of CR. This
could be tracked visually and quantified easily by UV-Vis. The specificity of the triggered
release system was tested in systems that reflected cell culture media and in full HS.
Despite the abundance of proteins contained within these solutions, AChE remained intact
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and only the addition of AtCh or paraoxon caused the release of CR.
The design of the detection system is highly advantageous due to the high degree
of specificity. Utilizing the enzyme-inhibitor pair for the triggered release system removes
the need for an additional influence, chemical or physical, to give a visual response. This
shows promise under biological conditions in which the addition of chemical or other
external triggers can be detrimental to the system. A self-contained system with direct
detection circumvents this problem. Additionally, this system helps eliminate false
positives and gives a fast visual indication that can be seen by the naked eye, allowing for
use by an untrained individual. The use of the enzyme-inhibitor triggered release system
has shown promise within the field of triggered response systems with minimal time to
synthesize the scaffold and the ability to tailor the material to the desired enzyme-inhibitor
pair.
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CHAPTER 4: DETERMINATION OF PHOSPHORYLATION RATE BY CONGO
RED RELEASE

4.1. Introduction
Nerve agent detection methods have continually evolved to help limit the
exposure of military and civilian personnel to these potentially deadly organophosphorus
compounds. Optical biosensors, particularly those based on colorimetric1-3 assays, have
several benefits including increased portability and real-time detection.4-15 Many of these
assays are inhibition-based detection systems measuring the change in activity of
acetylcholinesterase (AChE).15-20 The rationale for the use of AChE as the basis for these
biosensors lies with its interaction with organophosphates, resulting in the phosphorylation
of the AChE active site. The hydrolysis rate of acetylcholine by AChE can then be
measured before and after exposure to an organophosphate, and the kinetics determined.
Recently, the development of two direct response systems; one for detection and
decontamination using organophosphorus hydrolase (OPH) and the other using AChE for
increased sensitivity for detection were developed by our group. The use of a porous silica
support allowed a competitive inhibitor of each enzyme to be attached to the nanoparticle
surface, temporarily tethering the enzyme to the surface. This allowed the enzyme to block
the pores of the silica, acting as a triggered release mechanism when in the presence of a
substrate. In the case of AChE, organophosphates can also release the enzyme by
permanently modify its active site. If the interior pore volume of the silica is loaded with a
dye, the release of the enzyme caused release of the dye, which could be visually tracked
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with the naked eye, allowing for use by an untrained individual without complex
instrumentation and quantified by UV-Visible spectroscopy. The use of an enzymeinhibitor trigger allowed for high specificity of the system, in which release of the enzyme
occurred only in the presence of the substrate or organophosphate, for the AChE based
system (Figure 4.1).

Figure 4.1: Release of CR due to presence of substrate (hydrolysis) or organophosphate
(phosphorylation).

The initial purpose in designing these detection systems was to combine fast
detection with limited false positives, regardless of the specific organophosphate detected.
While the detection system using AChE does show a fast response, further experiments
were required to determine and compare the rates of release using different
organophosphates. Using the same mesoporous silica scaffold and competitive tacrine
inhibitor-AChE pair, described in Chapter 3, several organophosphates were tested and the
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kinetics of dye release compared to the rate of AChE phosphorylation.
4.2. Experimental Section

4.2.1. Materials and Instrumentation
See All materials were purchased from Sigma-Aldrich, VWR and Life
Technologies. UV/Vis spectra were measured using a Perkin-Elmer Lambda 35
spectrophotometer system. Thermogravimetric analysis (TGA) was performed on a
PerkinElmer Pyris 1 DSC-TGA. Scans were performed under a mixed flow of nitrogen
(85%) and oxygen (15%) between 25 °C and 800 °C at 20 °C/min with a thermal hold at
100°C for 15 minutes to remove any residual water. N2 adsorption and desorption
isotherms were obtained on a Micromeritics TriStar instrument. Surface areas were
measured using the Brunauer-Emmett-Teller (BET) method and pore size distributions
were calculated from a modified Kruk, Jaronic and Sayari (KJS) method using the
adsorption branch.
4.2.2. Synthesis, Functionalization and Characterization of APMS
4.2.2.1. Synthesis of Acid-Prepared Mesoporous Silica (APMS)
APMS was synthesized as previously described.21-22
4.2.2.2. Synthesis of APMS-(s)-NH2
Pore-blocked APMS (1.8 g) was suspended in hexanes (400 mL) to which 3aminoproplytriethoxysilane (APTES) (1.8 mL) was added. The solution was refluxed for
3.5 hours under an inert atmosphere (N2) to form the product APMS-(s)-NH2. To remove
surfactant from the pores, APMS-(s)-NH2 was extracted by refluxing with acidified ethanol
119

(0.1 M HCl in ethanol) for 24 hours (3X), filtering and letting dry between each cycle. The
degree of modification was characterized by thermogravimetric analysis (2.02 mmol
modification/g APMS) and the physical properties characterized by nitrogen physisorption.
The resulting APMS was then placed under vacuum to keep dry until further modification.
4.2.2.3. Synthesis of APMS-(s)-NH-COOH
Extracted APMS-(s)-NH2 (1.5 g) was suspended in acetonitrile (dry) under an
inert atmosphere (N2) to which triethylamine (950 µL) and succinic anhydride (355 mg)
was added. The solution was stirred at 60°C for 21.5 hours then collected by vacuum
filtration. Several washings with trifluoroacetic acid (0.1% in water) and acetonitrile were
followed by drying overnight. The degree of modification was characterized by
thermogravimetric analysis (0.61 mmol modification/g APMS) and the physical properties
characterized by nitrogen physisorption. The resulting APMS-(s)-NH-COOH was then
placed under vacuum to keep dry until further modification.
4.2.2.4. Synthesis of APMS-(s)-Tac
In a typical synthesis, APMS-(s)-NH-COOH (57 mg) was suspended in 8 mL
dimethylformamide (DMF) to which, hydroxybenzotriazole (HOBt) (82 mg), N, N’diisopropylcarbodiimide (90 mg) and 4-dimethylaminopyridine (DMAP) (4 mg) were
added and stirred for 1 hour. Tacrine hydrochloride (Tac) (14 mg) was then added and
stirred for 19 hours. The particles were collected by vacuum filtration and washed with
DMF then MeOH and left to dry overnight. The degree of modification (0.28 mmol
modification/g APMS) was determined by thermogravimetric analysis and the physical
properties characterized by nitrogen physisorption. The resulting APMS-(s)-Tac was then
120

placed under vacuum to keep dry until further modification.
4.2.3. Congo Red Loading and Release Using APMS-CR-(s)-Tac-AChE
4.2.3.1. Loading of Congo Red (APMS-CR-(s)-Tac)
In a typical loading procedure, Congo Red (CR) (40 mg) was added to a citrate
buffer (5 mL, 0.01 M, pH 3.98) to make a CR stock. APMS-(s)-Tac (4.0 mg) was shaken
(24 hr) with the CR stock (3 mL, 11.5 mM). The sample was centrifuged and the
supernatant measured by UV-Vis to determine the amount of CR loaded. The material was
washed once with citrate buffer and phosphate buffer (100 mM, pH = 7.3) to prepare for
loading with AChE.
4.2.3.2. Determination of [AChE]
Free AChE concentrations and AChE immobilized onto APMS-(s)-Tac were
calculated using a PierceTM BCA protein assay kit using a standard bovine serum albumin
(BSA) calibration curve.23 Triplicate samples measured for the standard curve.
4.2.3.3. Loading AChE (APMS-CR-(s)-Tac-AChE)
A typical loading required 4.0 mg APMS-CR-(s)-Tac suspended in a stock AChE
solution (508 µg/mL in phosphate buffer (100 mM, pH = 7.3)) and placed on a rotating
platform for 24 hours. The sample was centrifuged, supernatant removed and immobilized
AChE determined by the BCA assay. The particles were washed with phosphate buffer
until all non-encapsulated CR was removed. The particles were then re-suspended in the
appropriate amount of phosphate buffer for kinetics testing.
4.2.3.4. Release of Congo Red from APMS-CR-(s)-Tac-AChE
In a typical reaction, APMS-CR-(s)-Tac-AChE (0.11 mg AChE total, 0.608 µM)
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was suspended in phosphate buffer (629.18 µL, 100 mM, pH = 7.3). The sample was
shaken for 15 minutes, centrifuged and supernatant measure to show no CR releasing. An
aliquot of paraoxon was then added to give the desired concentration in solution (5.06, 7.08
or 8.23 mM). The sample was shaken for a set time interval (2.5 - 5 min) and the reaction
stopped by centrifugation. The supernatant was then measured by UV-Vis to measure the
amount of CR released based on a calibration curve. This procedure was repeated with
additional organophosphates (parathion, demeton-s and malathion), adjusting the
experimental conditions for the desired concentrations in solution.
4.2.3.5. Inhibition of AChE After Release from APMS-(s)-Tac-AChE
After release of CR from APMS-CR-(s)-Tac-AChE using demeton-s, the sample
was centrifuged and the supernatant removed. To the supernatant (200 µL), Ellman’s
reagent, 5, 5’-dithio-bis-(2-nitrobenzoic acid) (20 µL) and acetylthiocholine (AtCh) (2 µL)
from an AtCh stock (7.64 mM) was added. The reaction was allowed to react for 25 min
and measured by UV-Vis. This was compared to a background standard sample of the same
concentrations but without AChE and measured by UV-Vis.

4.3. Results
4.3.1. Preparation and Characterization of APMS-(s)-Tac
Synthesis and characterization was the same as described in Chapter 3. The material
designated APMS-(s)-Tac (med), was used that had 0.28 mmol tacrine per gram of APMS.
4.3.2. Release of CR from APMS-CR-(s)-Tac-AChE
The loading of CR and attachment of AChE was the same as described in Chapter
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3. Experiments were then performed to compare the rates of release using different
organophosphates. Prior to organophosphate addition, the particles were shaken for 15
minutes in phosphate buffer and the supernatant measured to ensure no CR was releasing.
An aliquot of organophosphate (paraoxon, parathion, demeton-s or malathion) was then
added, resulting in the desired concentration in solution (5.06, 7.08 and 8.23 mM). The
concentration of CR in the supernatant was measured after a set time interval of five
minutes to track the release of CR after detachment of AChE from the nanoparticle surface.
Varying the concentration of organophosphate and measuring the release of CR within a
set time period allowed for the plotting of this data in a Lineweaver-Burk plot to calculate
the release kinetics (Table 4.1) before the CR release plateau.

Table 4.1: CR release kinetics with different organophosphates.24-25
LD50

Vmax

Km

kcat

kcat/Km

(mg/m3)

(M/min)

(M)

(min-1)

(M-1 min-1)

Paraoxon

1

2.96 x 10-6

1.21 x 10-6

4.87

403

Parathion

35

1.88 x 10-6

1.92 x 10-6

3.09

160

Demeton-S

55

1.84 x 10-6

2.28 x 10-6

3.03
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Malathion

1330

3.88 x 10-7

2.55 x 10-6

0.64

25

Surrogate
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4.4. Discussion

4.4.1. Mechanism of Phosphorylation
Previous testing of the detection system with AtCh and paraoxon showed its high
specificity for these compounds. At this point, we were interested in exploring the ability
of this detection system to detect and decontaminate other, related organophosphates.
Differences among the organophosphates were controlled by the rate of phosphorylation
within the AChE active site. Increased toxicity results in increasing rates of AChE
phosphorylation, inhibiting the activity of AChE.26-27

Figure 4.2: Hydrolysis of acetylcholine within the AChE active site. 26

The AChE active site consists of a catalytic triad of serine (S), glutamic acid (E)
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and histidine (H) (Figure 4.2).26 The negatively charged glutamic acid interacts with the
positively charged nitrogen on ACh to stabilize ACh within the active site. The serine
hydroxyl is acetylated by ACh with the assistance of the nearby histidine, leading to the
release of choline. This is followed by a nucleophilic attack by a water molecule, causing
deacetylation and regenerating the enzyme. In the poisoning of AChE by
organophosphates, a similar process is followed by the rate of deacetylation is exceedingly
slow, varying depending on the substituents on the phosphorus atom. Thus, AChE cannot
function and a buildup of ACh occurs (Figure 4.3).26

Figure 4.3: Phosphorylation of the AChE active site.26

Inhibition of AChE by organophosphorus compounds has been characterized by
the inhibition constant, ki. This constant is comprised of two factors that control the overall
rate of inhibition. The first is the dissociation constant (Kd) that is determined by the affinity
of the organophosphate for the serine residue. The formation of the organophosphateenzyme intermediate relies heavily on the reactivity of the phosphorus ester and steric
constraints of the organophosphate. The second determining factor is based on the rate of
formation of the organophosphorus ester (kp), which has been shown to be controlled by
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the leaving group (X). Overall, these two rates determine the inhibition constant
(ki) for a particular organophosphate which is equal to kp/Kd.27-28 This provides a basis to
compare the rates at which organophosphates inhibit AChE.
4.4.2. Organophosphate Surrogates
Due to the extreme toxicity of organophosphate nerve agents, chemical surrogates
with similar structures are often used in a laboratory setting. These surrogates are usually
commercially available pesticides (Figure 4.4).26, 29 (these are not three dimensional at the
phosphorus center) Testing of the proposed detection system used surrogate species that
contained similar structure characteristics to both G and V-agents. In general, G-agents
contain a halide leaving group bound to the phosphorous (P-X) such as with sarin and Vagents contain a sulfur-containing leaving group (P-S) such as with VX.27

Figure 4.4: Nerve agents and organophosphate surrogates. 26, 29
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Altering the rate of phosphorylation has been a commonly pursued strategy in the
development of pesticides, giving a large library of surrogates to select from. The
surrogates selected (paraoxon, parathion, demeton-s, and malathion) were chosen to
represent a range of organophosphate structures. In particular, paraoxon and parathion were
used as G-agent surrogates, and demeton-s and malathion were selected as V-agent
surrogates.
One difference among these surrogates is the replacement of the P=O bond for a
P=S bond. This has shown to decrease the rate of phosphorylation due to the decreased
polarizability of the P=S bond. The electropositive character of the phosphorus atom that
is created by the P=O bond facilitates nucleophilic attack by the serine at the active site of
AChE. With this in mind, the rates of inhibition (ki) for free AChE have been previously
determined for several organophosphates such as paraoxon (2.9 x 105 M-1 min-1) and
demeton-s (1.0 x 103 M-1 min-1) for specific AChE sources such as an electric eel, used in
this work.28 These values are representative of the inhibition rate of AChE in which half of
the concentration of enzyme has been inhibited. This would allow for a comparison of each
of the selected surrogates species by the rates of AChE inhibition. With higher ki values,
the faster AChE will be released from the surface due to disruption of the inhibitor in the
enzyme active site and the opposite with smaller ki values. This can be used to track the
sensitivity of the system with decreasing rates of inhibition from paraoxon to parathion to
demeton-s to malathion.27 For direct comparison between all surrogates, the use of LD50
was used. This value represents the dose at which half of the population does not survive.
The LD50 for the mouse model (oral) was found to be 1, 35, 55, and 1330 mg/m3 for
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paraoxon, parathion, demeton-s, and malathion, respectively (Table 4.1).24-25
4.4.3. CR Release Kinetics
Disruption of the interaction between the competitive inhibitor tacrine (Tac) and
the active site of AChE can be caused by the substrate or organophosphate through two
different mechanisms. Competition between Tac and the substrate for the active site causes
the release of AChE from the scaffold, opening the pores and allowing CR to escape. The
AChE is now free to hydrolyze AtCh into product. The rate at which this occurs is
dependent on the substrate concentration. In the case of organophosphates, the
phosphorylation of the serine residue disrupts the interaction between Tac and AChE,
resulting in the uncapping of the pores and release of CR. AChE is now free but inactive
due to phosphorylation of the active site. The rate at which this response occurs is
dependent on the rate at which AChE is phosphorylated, (ki) determined by the fitment of
the organophosphate within the active and the reactivity of the organophosphorus ester.24
With the current detection system, the kinetics of CR release are related to the rate
at which AChE is released from the surface, which are in turn related to the rate of AChE
inhibition. Our expectation was therefore the rate of CR release should be highest for
paraoxon and lowest for malathion, based on their LD50 values (Table 4.1).24-25
Importantly, the AChE should also continue to be inhibited after release from the surface,
allowing successive cycles of CR release to occur upon repeated exposures to
organophosphorus compounds. To ensure that inhibition of the released AChE was
occurring, post-CR release, the activity of AChE was tested using the Ellman’s method3031

and confirmed inhibition with the lack of 2-nitro-5-thiobenzoate production. Because of
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these connections, the Michaelis-Menten kinetics model32 can be used to provide an
indirect assessment of organophosphorus inhibition of AChE.
Measurement of activity was determined by measuring the amount of CR released
within a time period after the addition of an aliquot of surrogate. This was then repeated
with several additional concentrations of the surrogate and measuring the amount of CR
released. For each surrogate, the rate of CR release compared to surrogate concentration
was used to create a Lineweaver-Burk plot to determine the release kinetics. CR release
was determined for each of the preselected surrogates and compared (Table 4.1). Using
the information calculated, several characteristics about the detection system can be
determined.
The maximum velocity (Vmax) for each of surrogates represents the maximum
release rate of CR from APMS-CR-(s)-Tac-AChE. This is directly related to the rate at
which AChE is released from the surface due to phosphorylation. From paraoxon to
malathion, the Vmax correlates with the decrease in phosphorylation rate of each surrogates
with the largest velocity reaching 2.96 x 10-6 M/min for paraoxon (Table 4.1). The Vmax
for parathion and demeton-s are similar with parathion having a slightly elevated velocity.
The similarity in rates can be attributed to a balance between the decreased polarizability
of having a P=S (parathion) versus a slower leaving group (demeton-s) both factors
resulting in changes to the rate of phosphorylation.27 Despite this, differentiation between
the surrogates was attainable and this differentiation was held constant throughout the rest
of the kinetic factor comparisons.
Typically, the Km is a measure of how much substrate is needed to reach Vmax/2.
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The smaller the Km, the less substrate that is needed to reach half of the maximum velocity.
This is controlled by the affinity the enzyme has for its substrate. The higher the affinity,
the faster substrate is converted to product. In the case of the current detection system, the
Km represents the same situation but is the affinity the substrate has for the enzyme.
Increased rates of phosphorylation are a direct result of the organophosphate reacting faster
with the enzyme, giving smaller Km values and the Km increasing with the decrease in
phosphorylation rates. This correlates directly with the CR release data (Table 4.1) in
which the Km values increase from paraoxon (1.21 x 10-2 M) to the largest for malathion
(2.55 x 10-2 M).
The kcat can be defined as the turn over number of an enzyme, representing the
number of substrate molecules that are converted to product per enzyme. The higher the
kcat, the more active the enzyme in substrate conversion. The measurement of kcat for the
triggered release system is based on the rate at which CR is released. This is controlled by
the displacement of AChE due to phosphorylation. The faster this process occurs results in
a higher kcat and is directly proportional to the rate of phosphorylation. This was seen with
an increase in the kcat of CR release from malathion to paraoxon (Table 4.1).
While the Vmax, Km, and kcat each define different aspects of the kinetics for an
enzyme and its substrate, variability in solvents and total enzyme concentration can hinder
comparisons between different enzymes. Commonly, the use of catalytic efficiency
(kcat/Km) defines the overall ability of an enzyme to convert substrate to product. While
experimental conditions and enzyme concentration remained the same, variability between
each of the surrogate species represents a wide range of structural and electronic
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differences that all influence the rate of phosphorylation. The use of kcat/Km for comparison
to the surrogates and the ability to discern between them. This results in the catalytic
efficiency of the system to be higher for stronger phosphorylating surrogates, i.e. larger kcat
and smaller Km. The kcat/Km for paraoxon compared to malathion represents the ability for
the detection system to differentiate between organophosphates by having a 16-fold
difference in catalytic efficiency for CR released between these two surrogates (403 M 1

min-1 versus 25 M-1min-1). Comparison of paraoxon catalytic efficiency to demeton-s (3-

fold) and parathion (2.5-fold) represents the sensitivity of the system by allowing for
differentiation based on the amount of CR released.

4.5. Conclusion
The ability for organophosphate detection systems to work fast and efficiently
decreases the probability for a civilian or military personnel to be exposed. This requires
ease of use of the system while limiting false positives. Using a direct response system that
is triggered directly by the organophosphate allows for a faster response time to determine
the threat of exposure faster and the appropriate next step to be taken. Using a mesoporous
silica scaffold, the proposed detection system uses the interior pore volume to hold a dye
and its release controlled by an enzyme-inhibitor pair trigger that responded distinctly to
different organophosphates.
The exterior modification of the scaffold, APMS, with the competitive inhibitor
tacrine was used to tether ACHE to the scaffold after loading the interior pore volume with
CR. AChE capped the pore of APMS and remained there until the presence of an
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organophosphate surrogate. Phosphorylation of AChE disrupted the enzyme-inhibitor
interaction, displacing AChE and releasing CR. This has been previously shown to be
tracked visually but more importantly could be quantified by UV-Vis. This allowed for the
direct determination of CR release kinetics based on the rate of phosphorylation of AChE
by each of the different surrogate organophosphates tested.
The design of the detection system to differentiate between organophosphates by
releasing CR consistent with the rate of phosphorylation is highly advantageous. The
ability for a detection system to quickly and easily discern the threat level of an exposed
area is crucial to limiting exposure. With the current enzyme-inhibitor trigger system using
the specific enzyme that becomes inhibited when exposed to a nerve agent, allows for the
response of the system to be directly proportional and limits false positives. This has shown
promise within triggered-release systems in which the specificity of the trigger can be
defined by the enzyme for its substrate.
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CHAPTER 5: CONCLUSION

The goal of this study was to develop a molecular recognition system for
organophosphate detection to eliminate the problem with false positives seen with previous
detection systems. To do this, the use of a MSN as the scaffold to contain the optical signal,
the dye Congo Red, is capped with an enzyme to block the pores to retain the loaded dye.
The mode of attachment of the enzyme (OPH or AChE) was through the use of a
competitive inhibitor of the enzyme. Testing of the triggered-release mechanism with
either substrate or organophosphates was thoroughly explored to test the stability of the
tethering, and relate the dye release kinetics to the rate of AChE inhibition.
In the first molecular recognition system utilized OPH for a dual detection and
decontamination system. The enzyme was tethered to the surface of the particle with the
competitive inhibitor DEABP. The competitive inhibition of OPH, both free in solution
and immobilized DEABP, was confirmed through enzyme kinetics testing using 31P NMR.
The competitive inhibition was used as the trigger for the release of OPH, uncapping the
pores and releasing of CR. Color change of the particles was used as visual indication,
along with quantification by UV-Vis. This system worked with not only the ideal
conditions, but within cell culture media containing a variety proteins and growth factors,
maintain the activity of OPH and detection of CR. While OPH had a fast rate of hydrolysis,
this hindered probing the release system further. As more paraoxon was added, free OPH
would hydrolyze the organophosphate faster than the OPH could be displaced from the
surface of APMS. The use of a sacrificial enzyme that would become inactive after its
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release would allow for further testing to be completed.
The selection of a sacrificial enzyme relied on an enzyme that would become
inactive after the addition of an organophosphate. Organophosphorus compounds target
AChE and inhibit the hydrolysis of ACh through inhibition of the AChE active site. This
would allow the use of AChE as a sacrificial enzyme that would release from the surface
of the particle, allowing CR to escape. For this system, the competitive inhibitor tacrine
was used to temporarily tether AChE to the surface of APMS. Confirmation of the
competitive inhibition was performed using the Ellman’s method to confirm the
competitive inhibition of tacrine. This would ensure that the enzyme was tethered through
its active site and would be displaced by the introduction of an organophosphate. Similar
testing to the OPH-based system, the visual color change of the particles was confirmed
and quantified by UV-Vis. Testing the system against false positives was conducted with
both the AChE substrate, AtCh, and paraoxon. This included phosphate buffer, FBS and
human serum, which CR released only after the introduction of AtCh or paraoxon. This
showed the benefit of having a molecular recognition system that only released in when
exposed to an organophosphate, despite having a large concentration of proteins in
solution.
The final exploration of the AChE-based detection system was testing against
different organophosphates. The nerve agent surrogates used were paraoxon, parathion,
demeton-s, and malathion, ranked from the highest rate of inhibition to the lowest. Changes
in the rate of AChE inhibition could be tracked with changes in the rate and amount of CR
released. The decrease in inhibition rate resulted in a slower release of AChE from the
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surface of APMS due to the disruption of the inhibitor-enzyme tether. The slower AChE
was released, the smaller amount of CR released from the material. The sensitivity of the
system to different inhibition rates represents the use of this system for the detection of a
variety of organophosphates, with an increased signal for faster inhibiting
organophosphates.
The use of an enzyme-inhibitor molecular recognition system shows promise in
the area of organophosphate detection by eliminating the problem with false positives and
giving a visual detection. The visual detection broadens the scope of use among untrained
individuals, and limiting the exposure to the population.
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